BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huh CG, Factor VM, Sánchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA. 2004;101:4477-4482. [PMID: 15070743 DOI: 10.1073/pnas.0306068101] [Cited by in Crossref: 527] [Cited by in F6Publishing: 513] [Article Influence: 29.3] [Reference Citation Analysis]
Number Citing Articles
1 Lorenz L, Axnick J, Buschmann T, Henning C, Urner S, Fang S, Nurmi H, Eichhorst N, Holtmeier R, Bódis K, Hwang JH, Müssig K, Eberhard D, Stypmann J, Kuss O, Roden M, Alitalo K, Häussinger D, Lammert E. Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival. Nature 2018;562:128-32. [PMID: 30258227 DOI: 10.1038/s41586-018-0522-3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 14.3] [Reference Citation Analysis]
2 Hoffmann K, Nagel AJ, Tanabe K, Fuchs J, Dehlke K, Ghamarnejad O, Lemekhova A, Mehrabi A. Markers of liver regeneration-the role of growth factors and cytokines: a systematic review. BMC Surg. 2020;20:31. [PMID: 32050952 DOI: 10.1186/s12893-019-0664-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
3 Okaty BW, Freret ME, Rood BD, Brust RD, Hennessy ML, deBairos D, Kim JC, Cook MN, Dymecki SM. Multi-Scale Molecular Deconstruction of the Serotonin Neuron System. Neuron 2015;88:774-91. [PMID: 26549332 DOI: 10.1016/j.neuron.2015.10.007] [Cited by in Crossref: 117] [Cited by in F6Publishing: 114] [Article Influence: 16.7] [Reference Citation Analysis]
4 Chae YK, Arya A, Chiec L, Shah H, Rosenberg A, Patel S, Raparia K, Choi J, Wainwright DA, Villaflor V. Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy? Oncotarget. 2017;8:100863-100898. [PMID: 29246028 DOI: 10.18632/oncotarget.19809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
5 Scheving LA, Zhang X, Threadgill DW, Russell WE. Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2016;311:G807-16. [PMID: 27586651 DOI: 10.1152/ajpgi.00423.2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
6 Favier RP, Spee B, Schotanus BA, van den Ingh TS, Fieten H, Brinkhof B, Viebahn CS, Penning LC, Rothuizen J. COMMD1-deficient dogs accumulate copper in hepatocytes and provide a good model for chronic hepatitis and fibrosis. PLoS One 2012;7:e42158. [PMID: 22879914 DOI: 10.1371/journal.pone.0042158] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
7 Goshima K, Nakase J, Xu Q, Matsumoto K, Tsuchiya H. Repair of segmental bone defects in rabbit tibia promoted by a complex of β-tricalcium phosphate and hepatocyte growth factor. J Orthop Sci 2012;17:639-48. [PMID: 22763716 DOI: 10.1007/s00776-012-0262-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
8 Tao Y, Wang M, Chen E, Tang H. Liver Regeneration: Analysis of the Main Relevant Signaling Molecules. Mediators Inflamm 2017;2017:4256352. [PMID: 28947857 DOI: 10.1155/2017/4256352] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 11.4] [Reference Citation Analysis]
9 Zhang C, Chang C, Li D, Zhang F, Xu C. The novel protein C3orf43 accelerates hepatocyte proliferation. Cell Mol Biol Lett 2017;22:21. [PMID: 28932249 DOI: 10.1186/s11658-017-0051-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Krebs NJ, Neville C, Vacanti JP. Cellular Transplants for Liver Diseases. Cellular Transplantation. Elsevier; 2007. pp. 215-40. [DOI: 10.1016/b978-012369415-7/50013-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Huang X, Lee F, Teng Y, Lingam CB, Chen Z, Sun M, Song Z, Balachander GM, Leo HL, Guo Q, Shah I, Yu H. Sequential drug delivery for liver diseases. Adv Drug Deliv Rev 2019;149-150:72-84. [PMID: 31734169 DOI: 10.1016/j.addr.2019.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Sonnemann KJ, Bement WM. Wound repair: toward understanding and integration of single-cell and multicellular wound responses. Annu Rev Cell Dev Biol 2011;27:237-63. [PMID: 21721944 DOI: 10.1146/annurev-cellbio-092910-154251] [Cited by in Crossref: 189] [Cited by in F6Publishing: 179] [Article Influence: 17.2] [Reference Citation Analysis]
13 Sun G, Irvine KD. Control of growth during regeneration. Curr Top Dev Biol 2014;108:95-120. [PMID: 24512707 DOI: 10.1016/B978-0-12-391498-9.00003-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
14 Lederer A, Seehofer D, Schirmeier A, Levasseur S, Stockmann M, Nüssler AK, Menger MD, Neuhaus P, Rayes N. Postoperative Bile Leakage Inhibits Liver Regeneration after 70% Hepatectomy in Rats. Journal of Investigative Surgery 2013;26:36-45. [DOI: 10.3109/08941939.2012.691603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
15 Horras CJ, Lamb CL, Mitchell KA. Regulation of hepatocyte fate by interferon-γ. Cytokine Growth Factor Rev 2011;22:35-43. [PMID: 21334249 DOI: 10.1016/j.cytogfr.2011.01.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 5.8] [Reference Citation Analysis]
16 Borowicz S, Principe DR, Dorman MJ, McHenry AJ, Sondarva G, Kumar S, Ananthanarayanan V, Simms PE, Hess A, Rana A. HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization. PLoS One 2021;16:e0252197. [PMID: 34185790 DOI: 10.1371/journal.pone.0252197] [Reference Citation Analysis]
17 Shanmukhappa K, Matte U, Degen JL, Bezerra JA. Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair. J Biol Chem. 2009;284:12917-12923. [PMID: 19286661 DOI: 10.1074/jbc.m807313200] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
18 Lee SK, Lee SC, Kim SJ. A novel cell-free strategy for promoting mouse liver regeneration: utilization of a conditioned medium from adipose-derived stem cells. Hepatol Int. 2015;9:310-320. [PMID: 25788187 DOI: 10.1007/s12072-014-9599-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
19 Gómez-quiroz L, Gutiérrez-ruiz M, Marquardt J, Factor V, Thorgeirsson S. Redox Regulation by HGF/c-Met in Liver Disease. Liver Pathophysiology. Elsevier; 2017. pp. 375-87. [DOI: 10.1016/b978-0-12-804274-8.00029-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Lu S, Xiong Q, Du K, Gan X, Wang X, Yang L, Wang Y, Ge F, He S. Comparative iTRAQ proteomics revealed proteins associated with lobed fin regeneration in Bichirs. Proteome Sci 2019;17:6. [PMID: 31832023 DOI: 10.1186/s12953-019-0153-0] [Reference Citation Analysis]
21 Montagne R, Berbon M, Doublet L, Debreuck N, Baranzelli A, Drobecq H, Leroy C, Delhem N, Porte H, Copin MC, Dansin E, Furlan A, Tulasne D. Necrosis- and apoptosis-related Met cleavages have divergent functional consequences. Cell Death Dis 2015;6:e1769. [PMID: 25996296 DOI: 10.1038/cddis.2015.132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
22 Song Y, Su M, Panchatsharam P, Rood D, Lai L. c-Met signalling is required for efficient postnatal thymic regeneration and repair. Immunology 2015;144:245-53. [PMID: 25074726 DOI: 10.1111/imm.12365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
23 Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S, Shalapour S, Yang L, Valasek MA, Lee S, Minnich K, Seki E, Tuckermann J, Sibilia M, Zucman-Rossi J, Karin M. Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling. Cancer Cell. 2018;33:1061-1077.e6. [PMID: 29894692 DOI: 10.1016/j.ccell.2018.05.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 21.3] [Reference Citation Analysis]
24 Mizuno S, Nakamura T. Hepatocyte Growth Factor. In: Cortes P, Mogensen CE, editors. The Diabetic Kidney. Totowa: Humana Press; 2006. pp. 225-53. [DOI: 10.1007/978-1-59745-153-6_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Factor VM, Seo D, Ishikawa T, Kaposi-Novak P, Marquardt JU, Andersen JB, Conner EA, Thorgeirsson SS. Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice. PLoS One. 2010;5. [PMID: 20862286 DOI: 10.1371/journal.pone.0012739] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
26 Molla NW, Hassanain MM, Fadel Z, Boucher LM, Madkhali A, Altahan RM, Alrijraji EA, Simoneau EB, Alamri H, Salman A. Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases. Curr Oncol. 2017;24:e233-e243. [PMID: 28680292 DOI: 10.3747/co.24.3133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Fujiyoshi M, Ozaki M. Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J Hepatobiliary Pancreat Sci. 2011;18:13-22. [PMID: 20607568 DOI: 10.1007/s00534-010-0304-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]
28 Simoni-Nieves A, Clavijo-Cornejo D, Salas-Silva S, Escobedo-Calvario A, Bucio L, Souza V, Gutiérrez-Ruiz MC, Miranda-Labra RU, Gomez-Quiroz LE. HGF/c-Met regulates p22phox subunit of the NADPH oxidase complex in primary mouse hepatocytes by transcriptional and post-translational mechanisms. Ann Hepatol 2021;25:100339. [PMID: 33675999 DOI: 10.1016/j.aohep.2021.100339] [Reference Citation Analysis]
29 Steinway SN, Dang H, You H, Rountree CB, Ding W. The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma. PLoS One. 2015;10:e0128159. [PMID: 26000702 DOI: 10.1371/journal.pone.0128159] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
30 He Y, Long J, Zhong W, Fu Y, Li Y, Lin S. Sustained endoplasmic reticulum stress inhibits hepatocyte proliferation via downregulation of c-Met expression. Mol Cell Biochem 2014;389:151-8. [PMID: 24390087 DOI: 10.1007/s11010-013-1936-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Falenta K, Rodaway A, Jones G, Wells C. Imaging haematopoietic cells recruitment to an acute wound in vivo identifies a role for c-Met signalling: C-MET INHIBITION AND WOUND RESPONSE. Journal of Microscopy 2013;250:200-9. [DOI: 10.1111/jmi.12035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
32 Scheving LA, Zhang X, Stevenson MC, Threadgill DW, Russell WE. Loss of hepatocyte EGFR has no effect alone but exacerbates carbon tetrachloride-induced liver injury and impairs regeneration in hepatocyte Met-deficient mice. Am J Physiol Gastrointest Liver Physiol 2015;308:G364-77. [PMID: 25414100 DOI: 10.1152/ajpgi.00364.2014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
33 Cao Z, Ye T, Sun Y, Ji G, Shido K, Chen Y, Luo L, Na F, Li X, Huang Z, Ko JL, Mittal V, Qiao L, Chen C, Martinez FJ, Rafii S, Ding BS. Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis. Sci Transl Med 2017;9:eaai8710. [PMID: 28855398 DOI: 10.1126/scitranslmed.aai8710] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 11.5] [Reference Citation Analysis]
34 Choi W, Lee J, Lee J, Lee SH, Kim S. Hepatocyte Growth Factor Regulates Macrophage Transition to the M2 Phenotype and Promotes Murine Skeletal Muscle Regeneration. Front Physiol 2019;10:914. [PMID: 31404148 DOI: 10.3389/fphys.2019.00914] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
35 Szabo R, Rasmussen AL, Moyer AB, Kosa P, Schafer JM, Molinolo AA, Gutkind JS, Bugge TH. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene 2011;30:2003-16. [PMID: 21217780 DOI: 10.1038/onc.2010.586] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 7.3] [Reference Citation Analysis]
36 Paranjpe S, Bowen WC, Bell AW, Nejak-bowen K, Luo J, Michalopoulos GK. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology 2007;45:1471-7. [DOI: 10.1002/hep.21570] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
37 Heynen GJ, Fonfara A, Bernards R. Resistance to targeted cancer drugs through hepatocyte growth factor signaling. Cell Cycle 2014;13:3808-17. [PMID: 25426675 DOI: 10.4161/15384101.2014.988033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
38 Riddiough GE, Fifis T, Muralidharan V, Perini MV, Christophi C. Searching for the link; mechanisms underlying liver regeneration and recurrence of colorectal liver metastasis post partial hepatectomy. J Gastroenterol Hepatol 2019;34:1276-86. [PMID: 30828863 DOI: 10.1111/jgh.14644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Duplaquet L, Kherrouche Z, Baldacci S, Jamme P, Cortot AB, Copin MC, Tulasne D. The multiple paths towards MET receptor addiction in cancer. Oncogene 2018;37:3200-15. [PMID: 29551767 DOI: 10.1038/s41388-018-0185-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
40 Sharma AD, Narain N, Händel EM, Iken M, Singhal N, Cathomen T, Manns MP, Schöler HR, Ott M, Cantz T. MicroRNA-221 regulates FAS-induced fulminant liver failure. Hepatology. 2011;53:1651-1661. [PMID: 21400558 DOI: 10.1002/hep.24243] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
41 Lee D, Sung ES, Ahn JH, An S, Huh J, You WK. Development of antibody-based c-Met inhibitors for targeted cancer therapy. Immunotargets Ther 2015;4:35-44. [PMID: 27471710 DOI: 10.2147/ITT.S37409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
42 Lupu L, Wiegand P, Hüttmann N, Rawer S, Kleinekofort W, Shugureva I, Kichkailo AS, Tomilin FN, Lazarev A, Berezovski MV, Przybylski M. Molecular Epitope Determination of Aptamer Complexes of the Multidomain Protein C-Met by Proteolytic Affinity-Mass Spectrometry. ChemMedChem 2020;15:363-9. [PMID: 31825565 DOI: 10.1002/cmdc.201900489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Li HM. Liver regeneration microenvironment in liver cancer: Research progress and prospect. Shijie Huaren Xiaohua Zazhi 2018; 26(26): 1529-1536 [DOI: 10.11569/wcjd.v26.i26.1529] [Reference Citation Analysis]
44 Glodde N, Bald T, van den Boorn-konijnenberg D, Nakamura K, O’donnell JS, Szczepanski S, Brandes M, Eickhoff S, Das I, Shridhar N, Hinze D, Rogava M, van der Sluis TC, Ruotsalainen JJ, Gaffal E, Landsberg J, Ludwig KU, Wilhelm C, Riek-burchardt M, Müller AJ, Gebhardt C, Scolyer RA, Long GV, Janzen V, Teng MW, Kastenmüller W, Mazzone M, Smyth MJ, Tüting T, Hölzel M. Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy. Immunity 2017;47:789-802.e9. [DOI: 10.1016/j.immuni.2017.09.012] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 23.4] [Reference Citation Analysis]
45 Arechederra M, Carmona R, González-Nuñez M, Gutiérrez-Uzquiza A, Bragado P, Cruz-González I, Cano E, Guerrero C, Sánchez A, López-Novoa JM, Schneider MD, Maina F, Muñoz-Chápuli R, Porras A. Met signaling in cardiomyocytes is required for normal cardiac function in adult mice. Biochim Biophys Acta 2013;1832:2204-15. [PMID: 23994610 DOI: 10.1016/j.bbadis.2013.08.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
46 Suárez-Causado A, Caballero-Díaz D, Bertrán E, Roncero C, Addante A, García-Álvaro M, Fernández M, Herrera B, Porras A, Fabregat I, Sánchez A. HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model. Biochim Biophys Acta 2015;1853:2453-63. [PMID: 26001768 DOI: 10.1016/j.bbamcr.2015.05.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
47 Wang Y, Fukuda T, Isaji T, Lu J, Gu W, Lee HH, Ohkubo Y, Kamada Y, Taniguchi N, Miyoshi E, Gu J. Loss of α1,6-fucosyltransferase suppressed liver regeneration: implication of core fucose in the regulation of growth factor receptor-mediated cellular signaling. Sci Rep 2015;5:8264. [PMID: 25652335 DOI: 10.1038/srep08264] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
48 Montagne R, Furlan A, Kherrouche Z, Tulasne D. [Thirty years of Met receptor research: from the discovery of an oncogene to the development of targeted therapies]. Med Sci (Paris) 2014;30:864-73. [PMID: 25311021 DOI: 10.1051/medsci/20143010013] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
49 Lai Y, Ushio N, Rahman MM, Katanoda Y, Ogihara K, Naya Y, Moriyama A, Iwanaga T, Saitoh Y, Sogawa T, Sunaga T, Momoi Y, Izumi H, Miyoshi N, Endo Y, Fujiki M, Kawaguchi H, Miura N. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma. Vet Comp Oncol 2018;16:288-96. [DOI: 10.1111/vco.12379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
50 Andres F, Iamele L, Meyer T, Stüber JC, Kast F, Gherardi E, Niemann HH, Plückthun A. Inhibition of the MET Kinase Activity and Cell Growth in MET-Addicted Cancer Cells by Bi-Paratopic Linking. J Mol Biol 2019;431:2020-39. [PMID: 30930049 DOI: 10.1016/j.jmb.2019.03.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
51 Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology. 2006;43:2-8. [PMID: 16374844 DOI: 10.1002/hep.21015] [Cited by in Crossref: 160] [Cited by in F6Publishing: 146] [Article Influence: 10.0] [Reference Citation Analysis]
52 Sipos F, Constantinovits M, Valcz G, Tulassay Z, Műzes G. Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis. World J Gastroenterol 2015; 21(28): 8569-8579 [PMID: 26229399 DOI: 10.3748/wjg.v21.i28.8569] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Machide M, Hashigasako A, Matsumoto K, Nakamura T. Contact Inhibition of Hepatocyte Growth Regulated by Functional Association of the c-Met/Hepatocyte Growth Factor Receptor and LAR Protein-tyrosine Phosphatase. Journal of Biological Chemistry 2006;281:8765-72. [DOI: 10.1074/jbc.m512298200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
54 Baldacci S, Kherrouche Z, Descarpentries C, Wislez M, Dansin E, Furlan A, Tulasne D, Cortot AB. [MET exon 14 splicing sites mutations: A new therapeutic opportunity in lung cancer]. Rev Mal Respir 2018;35:796-812. [PMID: 30174236 DOI: 10.1016/j.rmr.2018.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
55 Gómez-Quiroz LE, Factor VM, Kaposi-Novak P, Coulouarn C, Conner EA, Thorgeirsson SS. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis. J Biol Chem 2008;283:14581-9. [PMID: 18348981 DOI: 10.1074/jbc.M707733200] [Cited by in Crossref: 60] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
56 Takemura T, Yoshida Y, Kiso S, Saji Y, Ezaki H, Hamano M, Kizu T, Egawa M, Chatani N, Furuta K, Kamada Y, Iwamoto R, Mekada E, Higashiyama S, Hayashi N, Takehara T. Conditional knockout of heparin-binding epidermal growth factor-like growth factor in the liver accelerates carbon tetrachloride-induced liver injury in mice. Hepatol Res 2013;43:384-93. [PMID: 22882498 DOI: 10.1111/j.1872-034X.2012.01074.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
57 Kucharz J, Dumnicka P, Kusnierz-cabala B, Demkow T, Wiechno P. The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC). Med Oncol 2019;36. [DOI: 10.1007/s12032-018-1239-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
58 Chalenko Y, Sobyanin K, Sysolyatina E, Midiber K, Kalinin E, Lavrikova A, Mikhaleva L, Ermolaeva S. Hepatoprotective Activity of InlB321/15, the HGFR Ligand of Bacterial Origin, in CCI4-Induced Acute Liver Injury Mice. Biomedicines 2019;7:E29. [PMID: 30979058 DOI: 10.3390/biomedicines7020029] [Reference Citation Analysis]
59 Dai G, Bustamante JJ, Zou Y, Myronovych A, Bao Q, Kumar S, Soares MJ. Maternal hepatic growth response to pregnancy in the mouse. Exp Biol Med (Maywood) 2011;236:1322-32. [PMID: 21969712 DOI: 10.1258/ebm.2011.011076] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
60 Xu W, Hellerbrand C, Köhler UA, Bugnon P, Kan YW, Werner S, Beyer TA. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Lab Invest. 2008;88:1068-1078. [PMID: 18679376 DOI: 10.1038/labinvest.2008.75] [Cited by in Crossref: 136] [Cited by in F6Publishing: 132] [Article Influence: 9.7] [Reference Citation Analysis]
61 Demirci C, Ernst S, Alvarez-Perez JC, Rosa T, Valle S, Shridhar V, Casinelli GP, Alonso LC, Vasavada RC, García-Ocana A. Loss of HGF/c-Met signaling in pancreatic β-cells leads to incomplete maternal β-cell adaptation and gestational diabetes mellitus. Diabetes. 2012;61:1143-1152. [PMID: 22427375 DOI: 10.2337/db11-1154] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
62 Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol. 2011;26 Suppl 1:188-202. [PMID: 21199531 DOI: 10.1111/j.1440-1746.2010.06549.x] [Cited by in Crossref: 281] [Cited by in F6Publishing: 270] [Article Influence: 25.5] [Reference Citation Analysis]
63 Zhang XJ, Olsavszky V, Yin Y, Wang B, Engleitner T, Öllinger R, Schledzewski K, Koch PS, Rad R, Schmid RM, Friess H, Goerdt S, Hüser N, Géraud C, von Figura G, Hartmann D. Angiocrine Hepatocyte Growth Factor Signaling Controls Physiological Organ and Body Size and Dynamic Hepatocyte Proliferation to Prevent Liver Damage during Regeneration. Am J Pathol 2020;190:358-71. [PMID: 31783007 DOI: 10.1016/j.ajpath.2019.10.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
64 Mungunsukh O, Lee YH, Marquez AP, Cecchi F, Bottaro DP, Day RM. A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation. Am J Physiol Lung Cell Mol Physiol 2010;299:L905-14. [PMID: 20889677 DOI: 10.1152/ajplung.00094.2010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
65 Otsuka T, Horiguchi N, Kanda D, Kosone T, Yamazaki Y, Yuasa K, Sohara N, Kakizaki S, Sato K, Takagi H, Merlino G, Mori M. Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice. World J Gastroenterol 2005;11:7444-9. [PMID: 16437714 DOI: 10.3748/wjg.v11.i47.7444] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
66 Harris WP, Wong KM, Saha S, Dika IE, Abou-Alfa GK. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers. Semin Oncol 2018;45:116-23. [PMID: 30348531 DOI: 10.1053/j.seminoncol.2018.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
67 Clavijo-Cornejo D, Enriquez-Cortina C, López-Reyes A, Domínguez-Pérez M, Nuño N, Domínguez-Meraz M, Bucio L, Souza V, Factor VM, Thorgeirsson SS, Gutiérrez-Ruiz MC, Gómez-Quiroz LE. Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. Biochimie 2013;95:1177-84. [PMID: 23333744 DOI: 10.1016/j.biochi.2013.01.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
68 Van Mater D, Añó L, Blum JM, Webster MT, Huang W, Williams N, Ma Y, Cardona DM, Fan CM, Kirsch DG. Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway. Cancer Res 2015;75:605-14. [PMID: 25503558 DOI: 10.1158/0008-5472.CAN-14-2527] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
69 Eagleson KL, Campbell DB, Thompson BL, Bergman MY, Levitt P. The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res 2011;4:68-83. [PMID: 21328570 DOI: 10.1002/aur.172] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
70 Blechacz B, Mishra L. Hepatocellular carcinoma biology. Recent Results Cancer Res. 2013;190:1-20. [PMID: 22941010 DOI: 10.1007/978-3-642-16037-0_1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
71 Minamino T, Ito Y, Ohkubo H, Hosono K, Suzuki T, Sato T, Ae T, Shibuya A, Sakagami H, Narumiya S, Koizumi W, Majima M. Thromboxane A2 receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment. Toxicology and Applied Pharmacology 2012;259:104-14. [DOI: 10.1016/j.taap.2011.12.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
72 Alvarez-Perez JC, Ernst S, Demirci C, Casinelli GP, Mellado-Gil JM, Rausell-Palamos F, Vasavada RC, Garcia-Ocaña A. Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration. Diabetes 2014;63:216-23. [PMID: 24089510 DOI: 10.2337/db13-0333] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
73 Jing Y, Sun Q, Xiong X, Meng R, Tang S, Cao S, Bi Y, Zhu D. Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high-fat diet-fed mice. J Diabetes Investig 2019;10:251-60. [PMID: 30070033 DOI: 10.1111/jdi.12904] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
74 Liu J, Li C, Cheng S, Ya S, Gao D, Ding W. Large-scale high-density culture of hepatocytes in a liver microsystem with mimicked sinusoid blood flow. J Tissue Eng Regen Med 2018;12:2266-76. [PMID: 30350403 DOI: 10.1002/term.2758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Zhu C, Xu J, Li M, Zhao G, Cao H. Heterogeneity of c-Met expression in Chinese gastric cancer patients. Hum Pathol 2015;46:1901-7. [PMID: 26472163 DOI: 10.1016/j.humpath.2015.06.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
76 Ye J, Shirakigawa N, Ijima H. Hybrid organoids consisting of extracellular matrix gel particles and hepatocytes for transplantation. J Biosci Bioeng. 2015;120:231-237. [PMID: 25660569 DOI: 10.1016/j.jbiosc.2015.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
77 Cui X, Ma B, Wang Y, Chen Y, Shen C, Kuang Y, Fei J, Lu L, Wang Z. Rdh13 deficiency weakens carbon tetrachloride-induced liver injury by regulating Spot14 and Cyp2e1 expression levels. Front Med 2019;13:104-11. [PMID: 29656332 DOI: 10.1007/s11684-017-0568-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Böhm F, Köhler UA, Speicher T, Werner S. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2010;2:294-305. [PMID: 20652897 DOI: 10.1002/emmm.201000085] [Cited by in Crossref: 135] [Cited by in F6Publishing: 139] [Article Influence: 11.3] [Reference Citation Analysis]
79 Desole C, Gallo S, Vitacolonna A, Vigna E, Basilico C, Montarolo F, Zuppini F, Casanova E, Miggiano R, Ferraris DM, Bertolotto A, Comoglio PM, Crepaldi T. Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor. Front Immunol 2021;12:775151. [PMID: 34925346 DOI: 10.3389/fimmu.2021.775151] [Reference Citation Analysis]
80 Shah MA, Wainberg ZA, Catenacci DV, Hochster HS, Ford J, Kunz P, Lee FC, Kallender H, Cecchi F, Rabe DC, Keer H, Martin AM, Liu Y, Gagnon R, Bonate P, Liu L, Gilmer T, Bottaro DP. Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. PLoS One 2013;8:e54014. [PMID: 23516391 DOI: 10.1371/journal.pone.0054014] [Cited by in Crossref: 124] [Cited by in F6Publishing: 131] [Article Influence: 13.8] [Reference Citation Analysis]
81 Koblish H, Li YL, Shin N, Hall L, Wang Q, Wang K, Covington M, Marando C, Bowman K, Boer J, Burke K, Wynn R, Margulis A, Reuther GW, Lambert QT, Dostalik Roman V, Zhang K, Feng H, Xue CB, Diamond S, Hollis G, Yeleswaram S, Yao W, Huber R, Vaddi K, Scherle P. Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies. PLoS One 2018;13:e0199108. [PMID: 29927999 DOI: 10.1371/journal.pone.0199108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
82 Dhanda AD, Lee RW, Collins PL, McCune CA. Molecular targets in the treatment of alcoholic hepatitis. World J Gastroenterol 2012; 18(39): 5504-5513 [PMID: 23112542 DOI: 10.3748/wjg.v18.i39.5504] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
83 Ma X, Chen K, Lu Z, Piechowicz M, Liu Q, Wu J, Qiu S. Disruption of MET Receptor Tyrosine Kinase, an Autism Risk Factor, Impairs Developmental Synaptic Plasticity in the Hippocampus. Dev Neurobiol 2019;79:36-50. [PMID: 30304576 DOI: 10.1002/dneu.22645] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
84 Mizuguchi T, Nagayama M, Meguro M, Shibata T, Kaji S, Nobuoka T, Kimura Y, Furuhata T, Hirata K. Prognostic Impact of Surgical Complications and Preoperative Serum Hepatocyte Growth Factor in Hepatocellular Carcinoma Patients After Initial Hepatectomy. J Gastrointest Surg 2009;13:325-33. [DOI: 10.1007/s11605-008-0711-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
85 Navarro-Alvarez N, Soto-Gutierrez A, Kobayashi N. Hepatic stem cells and liver development. Methods Mol Biol. 2010;640:181-236. [PMID: 20645053 DOI: 10.1007/978-1-60761-688-7_10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
86 Pauta M, Rotllan N, Vales F, Fernandez-Hernando A, Allen RM, Ford DA, Marí M, Jiménez W, Baldán A, Morales-Ruiz M, Fernández-Hernando C. Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids. J Hepatol 2013;59:731-7. [PMID: 23712050 DOI: 10.1016/j.jhep.2013.05.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
87 Thompson BL, Levitt P. Complete or partial reduction of the Met receptor tyrosine kinase in distinct circuits differentially impacts mouse behavior. J Neurodev Disord 2015;7:35. [PMID: 26523156 DOI: 10.1186/s11689-015-9131-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
88 Liu L, Norman MH, Lee M, Xi N, Siegmund A, Boezio AA, Booker S, Choquette D, D'Angelo ND, Germain J, Yang K, Yang Y, Zhang Y, Bellon SF, Whittington DA, Harmange JC, Dominguez C, Kim TS, Dussault I. Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series. J Med Chem 2012;55:1868-97. [PMID: 22320327 DOI: 10.1021/jm201331s] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
89 Fausto N, Riehle KJ. Mechanisms of liver regeneration and their clinical implications. J Hepatobiliary Pancreat Surg. 2005;12:181-189. [PMID: 15995805 DOI: 10.1007/s00534-005-0979-y] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 5.5] [Reference Citation Analysis]
90 Merchant M, Ma X, Maun HR, Zheng Z, Peng J, Romero M, Huang A, Yang NY, Nishimura M, Greve J. Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. Proc Natl Acad Sci USA. 2013;110:E2987-E2996. [PMID: 23882082 DOI: 10.1073/pnas.1302725110] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 15.9] [Reference Citation Analysis]
91 Russo AJ, Krigsman A, Jepson B, Wakefield A. Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease. Biomark Insights 2009;4:181-90. [PMID: 20029653 DOI: 10.4137/bmi.s3656] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
92 Salazar-Montes A, Ruiz-Corro L, Sandoval-Rodriguez A, Lopez-Reyes A, Armendariz-Borunda J. Increased DNA binding activity of NF-kB, STAT-3, SMAD3 and AP-1 in acutely damaged liver. World J Gastroenterol 2006; 12(37): 5995-6001 [PMID: 17009398 DOI: 10.3748/wjg.v12.i37.5995] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
93 Sato H, Imamura R, Suga H, Matsumoto K, Sakai K. Cyclic Peptide-Based Biologics Regulating HGF-MET. Int J Mol Sci 2020;21:E7977. [PMID: 33121208 DOI: 10.3390/ijms21217977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Kojima T, Funato Y, Miki H. Phosphatase of regenerating liver sensitizes MET to functional activation by hepatocyte growth factor. Biochem J 2019;476:1419-31. [PMID: 31036720 DOI: 10.1042/BCJ20190071] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 Sánchez A, Fabregat I. Growth factor- and cytokine-driven pathways governing liver stemness and differentiation. World J Gastroenterol 2010; 16(41): 5148-5161 [PMID: 21049549 DOI: 10.3748/wjg.v16.i41.5148] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
96 Arsura M, Cavin LG. Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett. 2005;229:157-169. [PMID: 16125305 DOI: 10.1016/j.canlet.2005.07.008] [Cited by in Crossref: 118] [Cited by in F6Publishing: 114] [Article Influence: 6.9] [Reference Citation Analysis]
97 Bai H, Zhang N, Xu Y, Chen Q, Khan M, Potter JJ, Nayar SK, Cornish T, Alpini G, Bronk S. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology. 2012;56:1097-1107. [PMID: 22886419 DOI: 10.1002/hep.25769] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
98 Gao L, Utsumi T, Tashiro K, Liu B, Zhang D, Swenson ES, Iwakiri Y. Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice. Hepatology 2013;57:1992-2003. [PMID: 23299899 DOI: 10.1002/hep.26235] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
99 Cho IJ, Sung DK, Kang KW, Kim SG. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation. Arch Pharm Res. 2009;32:625-635. [PMID: 19407981 DOI: 10.1007/s12272-009-1419-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
100 Ma J, Tan X, Kwon Y, Delgado ER, Zarnegar A, DeFrances MC, Duncan AW, Zarnegar R. A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00221-6. [PMID: 34756982 DOI: 10.1016/j.jcmgh.2021.10.007] [Reference Citation Analysis]
101 Li HM, Ye ZH. Microenvironment of liver regeneration in liver cancer. Chin J Integr Med 2017;23:555-60. [PMID: 28523536 DOI: 10.1007/s11655-017-2806-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
102 Zorde-Khvalevsky E, Abramovitch R, Barash H, Spivak-Pohis I, Rivkin L, Rachmilewitz J, Galun E, Giladi H. Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology. 2009;50:198-206. [PMID: 19441101 DOI: 10.1002/hep.22973] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
103 Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M, Feinstone SM, Thorgeirsson SS. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology. 2006;44:1478-1486. [PMID: 17133486 DOI: 10.1002/hep.21441] [Cited by in Crossref: 112] [Cited by in F6Publishing: 97] [Article Influence: 7.5] [Reference Citation Analysis]
104 Hodgson H. c-met—there when it's needed? Journal of Hepatology 2005;43:544-6. [DOI: 10.1016/j.jhep.2005.06.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Chiang KY, Li YW, Li YH, Huang SJ, Wu CL, Gong HY, Wu JL. Progranulin A Promotes Compensatory Hepatocyte Proliferation via HGF/c-Met Signaling after Partial Hepatectomy in Zebrafish. Int J Mol Sci 2021;22:11217. [PMID: 34681875 DOI: 10.3390/ijms222011217] [Reference Citation Analysis]
106 Towner RA, Smith N, Tesiram YA, Abbott A, Saunders D, Blindauer R, Herlea O, Silasi-mansat R, Lupu F. In Vivo Detection of c-MET Expression in a Rat Hepatocarcinogenesis Model Using Molecularly Targeted Magnetic Resonance Imaging. Mol Imaging 2007;6:7290.2006.00031. [DOI: 10.2310/7290.2006.00031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
107 Parachoniak CA, Park M. Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase. J Biol Chem 2009;284:8382-94. [PMID: 19109251 DOI: 10.1074/jbc.M807607200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
108 Pérez-calvo J, Morales-rull J, Gimeno-orna J, Lasierra-díaz P, Josa-laorden C, Puente-lanzarote J, Bettencourt P, Pascual-figal DA. Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized With Acute Heart Failure Regardless of Ejection Fraction. The American Journal of Cardiology 2016;118:543-9. [DOI: 10.1016/j.amjcard.2016.05.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
109 Okunishi K, Dohi M, Fujio K, Nakagome K, Tabata Y, Okasora T, Seki M, Shibuya M, Imamura M, Harada H, Tanaka R, Yamamoto K. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol 2007;179:5504-13. [PMID: 17911637 DOI: 10.4049/jimmunol.179.8.5504] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
110 Mungunsukh O, McCart EA, Day RM. Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling. Biomedicines 2014;2:301-26. [PMID: 28548073 DOI: 10.3390/biomedicines2040301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
111 Naugler WE. Bile acid flux is necessary for normal liver regeneration. PLoS One 2014;9:e97426. [PMID: 24841254 DOI: 10.1371/journal.pone.0097426] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
112 Zhang F, Shu R, Wu X, Zhao X, Feng D, Wang L, Lu S, Liu Q, Xiang Y, Fei J, Huang L, Wang Z. Delayed liver injury and impaired hepatocyte proliferation after carbon tetrachloride exposure in BPOZ2-deficient mice. Toxicol Lett 2009;188:201-7. [PMID: 19393728 DOI: 10.1016/j.toxlet.2009.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
113 Li FF, Zheng H, Xu WX, Yang XM, Wang SY. Activation of TEC and STAT3 after partial hepatectomy or hepatocytic growth factor stimulation. Shijie Huaren Xiaohua Zazhi 2004; 12(12): 2809-2812 [DOI: 10.11569/wcjd.v12.i12.2809] [Reference Citation Analysis]
114 Li JW, Wang GP, Fan JY, Chang CF, Xu CS. Eight paths of ERK1/2 signalling pathway regulating hepatocyte proliferation in rat liver regeneration. J Genet 2011;90:435-42. [DOI: 10.1007/s12041-011-0107-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
115 Gelsomino F, Facchinetti F, Haspinger E, Garassino M, Trusolino L, De Braud F, Tiseo M. Targeting the MET gene for the treatment of non-small-cell lung cancer. Critical Reviews in Oncology/Hematology 2014;89:284-99. [DOI: 10.1016/j.critrevonc.2013.11.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
116 Di-Poï N, Ng CY, Tan NS, Yang Z, Hemmings BA, Desvergne B, Michalik L, Wahli W. Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development. Mol Cell Biol 2005;25:1696-712. [PMID: 15713628 DOI: 10.1128/MCB.25.5.1696-1712.2005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
117 Moteki H, Kimura M, Sunaga K, Tsuda T, Ogihara M. Signal transduction mechanism for potentiation by α1- and β2-adrenoceptor agonists of L-ascorbic acid-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. Eur J Pharmacol 2013;700:2-12. [PMID: 23270716 DOI: 10.1016/j.ejphar.2012.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
118 Genestine M, Caricati E, Fico A, Richelme S, Hassani H, Sunyach C, Lamballe F, Panzica GC, Pettmann B, Helmbacher F, Raoul C, Maina F, Dono R. Enhanced neuronal Met signalling levels in ALS mice delay disease onset. Cell Death Dis 2011;2:e130. [PMID: 21412276 DOI: 10.1038/cddis.2011.11] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
119 Lieu HT, Simon MT, Nguyen-Khoa T, Kebede M, Cortes A, Tebar L, Smith AJ, Bayne R, Hunt SP, Bréchot C, Christa L. Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice. Hepatology 2006;44:1452-64. [PMID: 17133485 DOI: 10.1002/hep.21434] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
120 Benvenuti S, Comoglio PM. The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 2007;213:316-25. [DOI: 10.1002/jcp.21183] [Cited by in Crossref: 193] [Cited by in F6Publishing: 204] [Article Influence: 12.9] [Reference Citation Analysis]
121 Koeberl DD, Pinto C, Sun B, Li S, Kozink DM, Benjamin DK, Demaster AK, Kruse MA, Vaughn V, Hillman S, Bird A, Jackson M, Brown T, Kishnani PS, Chen Y. AAV Vector-mediated Reversal of Hypoglycemia in Canine and Murine Glycogen Storage Disease Type Ia. Molecular Therapy 2008;16:665-72. [DOI: 10.1038/mt.2008.15] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
122 Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, Persico AM. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol 2007;62:243-50. [PMID: 17696172 DOI: 10.1002/ana.21180] [Cited by in Crossref: 127] [Cited by in F6Publishing: 127] [Article Influence: 8.5] [Reference Citation Analysis]
123 Yamamoto K, Sasakawa Y, Nakaoka F, Nakao M, Nakamura M, Kominami A, Abe M, Fukuhama C, Kagawa K. Effect of globin digest on the liver injury and hepatic gene expression profile in galactosamine-induced liver injury in SD rats. Life Sci 2011;88:701-12. [PMID: 21334349 DOI: 10.1016/j.lfs.2011.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
124 Kakani P, Suman S, Gupta L, Kumar S. Ambivalent Outcomes of Cell Apoptosis: A Barrier or Blessing in Malaria Progression. Front Microbiol 2016;7:302. [PMID: 27014225 DOI: 10.3389/fmicb.2016.00302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
125 Gu TL, Deng X, Huang F, Tucker M, Crosby K, Rimkunas V, Wang Y, Deng G, Zhu L, Tan Z. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One. 2011;6:e15640. [PMID: 21253578 DOI: 10.1371/journal.pone.0015640] [Cited by in Crossref: 197] [Cited by in F6Publishing: 200] [Article Influence: 17.9] [Reference Citation Analysis]
126 Locatelli A, Lange CA. Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members. J Biol Chem 2011;286:21062-72. [PMID: 21489997 DOI: 10.1074/jbc.M110.211409] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
127 Fu L, Guo W, Liu B, Sun L, Bi Z, Zhu L, Wang X, Liu B, Xie Q, Li K. Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer. Biomarkers. 2013;18:126-135. [PMID: 23410046 DOI: 10.3109/1354750X.2012.751455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
128 Marquardt JU, Seo D, Gómez-Quiroz LE, Uchida K, Gillen MC, Kitade M, Kaposi-Novak P, Conner EA, Factor VM, Thorgeirsson SS. Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways. Biochim Biophys Acta. 2012;1822:942-951. [PMID: 22386877 DOI: 10.1016/j.bbadis.2012.02.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
129 Lee JK, Abou-Alfa GK. An update on clinical trials in the treatment of advanced hepatocellular carcinoma. J Clin Gastroenterol 2013;47 Suppl:S16-9. [PMID: 23751800 DOI: 10.1097/MCG.0b013e31827d77a2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
130 Li J, Li J, Zhang J, Shi J, Ding S, Liu Y, Chen Y, Liu J. Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors. Anticancer Agents Med Chem 2020;20:559-70. [PMID: 31893997 DOI: 10.2174/1871520620666200101143307] [Reference Citation Analysis]
131 Parachoniak CA, Luo Y, Abella JV, Keen JH, Park M. GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration. Dev Cell 2011;20:751-63. [PMID: 21664574 DOI: 10.1016/j.devcel.2011.05.007] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 8.8] [Reference Citation Analysis]
132 Wang SY, Li FF, Zheng H, Yu KK, Ni F, Yang XM, Qu CK, Li J. Rapid induction and activation of Tec tyrosine kinase in liver regeneration. J Gastroenterol Hepatol 2006;21:668-73. [PMID: 16677151 DOI: 10.1111/j.1440-1746.2006.04259.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
133 Amaya MJ, Nathanson MH. Calcium signaling in the liver. Compr Physiol 2013;3:515-39. [PMID: 23720295 DOI: 10.1002/cphy.c120013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
134 Malik R, Mambetsariev I, Fricke J, Chawla N, Nam A, Pharaon R, Salgia R. MET receptor in oncology: From biomarker to therapeutic target. Adv Cancer Res 2020;147:259-301. [PMID: 32593403 DOI: 10.1016/bs.acr.2020.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
135 Oliveres H, Pineda E, Maurel J. MET inhibitors in cancer: pitfalls and challenges. Expert Opin Investig Drugs 2020;29:73-85. [PMID: 31783719 DOI: 10.1080/13543784.2020.1699532] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
136 Correnti JM, Cook D, Aksamitiene E, Swarup A, Ogunnaike B, Vadigepalli R, Hoek JB. Adiponectin fine-tuning of liver regeneration dynamics revealed through cellular network modelling. J Physiol 2015;593:365-83. [PMID: 25630259 DOI: 10.1113/jphysiol.2014.284109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
137 Nakayama M, Sakai K, Yamashita A, Nakamura T, Suzuki Y, Matsumoto K. Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes. Cytokine. 2013;62:446-452. [PMID: 23618918 DOI: 10.1016/j.cyto.2013.04.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
138 Imamura R, Matsumoto K. Hepatocyte growth factor in physiology and infectious diseases. Cytokine 2017;98:97-106. [PMID: 28094206 DOI: 10.1016/j.cyto.2016.12.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
139 Della Fazia MA, Servillo G. Foie gras and liver regeneration: a fat dilemma. Cell Stress 2018;2:162-75. [PMID: 31225483 DOI: 10.15698/cst2018.07.144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
140 Mason S, Hader C, Marlier A, Moeckel G, Cantley LG. Met activation is required for early cytoprotection after ischemic kidney injury. J Am Soc Nephrol 2014;25:329-37. [PMID: 24136921 DOI: 10.1681/ASN.2013050473] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
141 Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M, Hui L, Wagner EF. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev. 2006;20:2306-2314. [PMID: 16912279 DOI: 10.1101/gad.390506] [Cited by in Crossref: 146] [Cited by in F6Publishing: 144] [Article Influence: 9.1] [Reference Citation Analysis]
142 Wang H, Zhang Y, Heuckeroth RO. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice. Hepatology. 2007;45:1527-1537. [PMID: 17538930 DOI: 10.1002/hep.21613] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
143 Ishibashi H, Tonomura H, Ikeda T, Nagae M, Sakata M, Fujiwara H, Tanida T, Mastuda K, Kawata M, Kubo T. Hepatocyte growth factor/c-met promotes proliferation, suppresses apoptosis, and improves matrix metabolism in rabbit nucleus pulposus cells in vitro. J Orthop Res 2016;34:709-16. [PMID: 26440443 DOI: 10.1002/jor.23063] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
144 Madonna R, Bolli R, Rokosh G, De Caterina R. Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection: . Journal of Cardiovascular Medicine 2013;14:249-53. [DOI: 10.2459/jcm.0b013e3283542017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
145 Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D, Sato TN, Rabbany SY, Rafii S. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310-315. [PMID: 21068842 DOI: 10.1038/nature09493] [Cited by in Crossref: 494] [Cited by in F6Publishing: 464] [Article Influence: 41.2] [Reference Citation Analysis]
146 Wang Y, Yu A, Yu FX. The Hippo pathway in tissue homeostasis and regeneration. Protein Cell 2017;8:349-59. [PMID: 28130761 DOI: 10.1007/s13238-017-0371-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 12.0] [Reference Citation Analysis]
147 Wang C, de Mochel NSR, Christenson SA, Cassandras M, Moon R, Brumwell AN, Byrnes LE, Li A, Yokosaki Y, Shan P, Sneddon JB, Jablons D, Lee PJ, Matthay MA, Chapman HA, Peng T. Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype. J Clin Invest 2018;128:4343-58. [PMID: 29999500 DOI: 10.1172/JCI99435] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
148 Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS Biol 2006;4:e83. [PMID: 16509772 DOI: 10.1371/journal.pbio.0040083] [Cited by in Crossref: 313] [Cited by in F6Publishing: 295] [Article Influence: 19.6] [Reference Citation Analysis]
149 Yılmaz Y, Güneş A, Topel H, Atabey N. Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis. J Gastrointest Cancer 2017;48:225-37. [PMID: 28819741 DOI: 10.1007/s12029-017-9958-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
150 Ishikawa H, Jo J, Tabata Y. Liver Anti-Fibrosis Therapy with Mesenchymal Stem Cells Secreting Hepatocyte Growth Factor. J Biomater Sci Polym Ed 2012;23:2259-72. [PMID: 22182291 DOI: 10.1163/156856211X614761] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
151 Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene 2007;26:2925-38. [DOI: 10.1038/sj.onc.1210088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
152 Lim A, Shin K, Zhao C, Kawano S, Beachy PA. Spatially restricted Hedgehog signalling regulates HGF-induced branching of the adult prostate. Nat Cell Biol 2014;16:1135-45. [PMID: 25362352 DOI: 10.1038/ncb3057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
153 Seiwert TY, Beck TN, Salgia R. The Role of HGF/c-MET in Head and Neck Squamous Cell Carcinoma. In: Burtness B, Golemis EA, editors. Molecular Determinants of Head and Neck Cancer. New York: Springer; 2014. pp. 91-111. [DOI: 10.1007/978-1-4614-8815-6_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
154 Méndez JD, Hernández RDH, Conejo VA. Spermine increases arginase activity in the liver after carbon tetrachloride-induced hepatic injury in Long-Evans rats. Biomedicine & Pharmacotherapy 2006;60:82-5. [DOI: 10.1016/j.biopha.2005.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
155 Tackett BC, Sun H, Mei Y, Maynard JP, Cheruvu S, Mani A, Hernandez-Garcia A, Vigneswaran N, Karpen SJ, Thevananther S. P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 2014;307:G1073-87. [PMID: 25301185 DOI: 10.1152/ajpgi.00092.2014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
156 Heukers R, Altintas I, Raghoenath S, De Zan E, Pepermans R, Roovers RC, Haselberg R, Hennink WE, Schiffelers RM, Kok RJ, van Bergen en Henegouwen PM. Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles. Biomaterials 2014;35:601-10. [DOI: 10.1016/j.biomaterials.2013.10.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
157 Dias IB, Bouma HR, Henning RH. Unraveling the Big Sleep: Molecular Aspects of Stem Cell Dormancy and Hibernation. Front Physiol 2021;12:624950. [PMID: 33867999 DOI: 10.3389/fphys.2021.624950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Dai C, Saleem MA, Holzman LB, Mathieson P, Liu Y. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int 2010;77:962-73. [PMID: 20375988 DOI: 10.1038/ki.2010.40] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
159 Zou C, Ma J, Wang X, Guo L, Zhu Z, Stoops J, Eaker AE, Johnson CJ, Strom S, Michalopoulos GK, DeFrances MC, Zarnegar R. Lack of Fas antagonism by Met in human fatty liver disease. Nat Med 2007;13:1078-85. [PMID: 17704785 DOI: 10.1038/nm1625] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
160 Ellison GM, Smith AJ, Waring CD, Henning BJ, Burdina AO, Polydorou J, Vicinanza C, Lewis FC, Nadal-ginard B, Torella D. Adult Cardiac Stem Cells: Identity, Location and Potential. In: Turksen K, editor. Adult Stem Cells. New York: Springer; 2014. pp. 47-90. [DOI: 10.1007/978-1-4614-9569-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 D'Alessandro LA, Samaga R, Maiwald T, Rho SH, Bonefas S, Raue A, Iwamoto N, Kienast A, Waldow K, Meyer R, Schilling M, Timmer J, Klamt S, Klingmüller U. Disentangling the Complexity of HGF Signaling by Combining Qualitative and Quantitative Modeling. PLoS Comput Biol 2015;11:e1004192. [PMID: 25905717 DOI: 10.1371/journal.pcbi.1004192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
162 Ferraris DM, Gherardi E, Di Y, Heinz DW, Niemann HH. Ligand-mediated dimerization of the Met receptor tyrosine kinase by the bacterial invasion protein InlB. J Mol Biol 2010;395:522-32. [PMID: 19900460 DOI: 10.1016/j.jmb.2009.10.074] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
163 Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, Khokha R. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 2005;41:857-67. [DOI: 10.1002/hep.20618] [Cited by in Crossref: 106] [Cited by in F6Publishing: 103] [Article Influence: 6.2] [Reference Citation Analysis]
164 Holmes O, Pillozzi S, Deakin JA, Carafoli F, Kemp L, Butler PJ, Lyon M, Gherardi E. Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains. J Mol Biol 2007;367:395-408. [PMID: 17258232 DOI: 10.1016/j.jmb.2006.12.061] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
165 Ma H, Saenko M, Opuko A, Togawa A, Soda K, Marlier A, Moeckel GW, Cantley LG, Ishibe S. Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstruction. Kidney Int. 2009;76:868-876. [PMID: 19675527 DOI: 10.1038/ki.2009.304] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
166 Migliore C, Giordano S. Molecular cancer therapy: can our expectation be MET? Eur J Cancer 2008;44:641-51. [PMID: 18295476 DOI: 10.1016/j.ejca.2008.01.022] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 6.2] [Reference Citation Analysis]
167 Gonçalves LA, Almeida P, Mota MM, Penha-Gonçalves C. Malaria liver stage susceptibility locus identified on mouse chromosome 17 by congenic mapping. PLoS One 2008;3:e1874. [PMID: 18365019 DOI: 10.1371/journal.pone.0001874] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
168 Ozaki M. Cellular and molecular mechanisms of liver regeneration: Proliferation, growth, death and protection of hepatocytes. Semin Cell Dev Biol 2020;100:62-73. [PMID: 31669133 DOI: 10.1016/j.semcdb.2019.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
169 Bello-Monroy O, Mata-Espinosa D, Enríquez-Cortina C, Souza V, Miranda RU, Bucio L, Barrios-Payán J, Marquina-Castillo B, Rodríguez-Ochoa I, Rosales P, Gutiérrez-Ruiz MC, Hernández-Pando R, Gomez-Quiroz LE. Hepatocyte growth factor enhances the clearance of a multidrug-resistant Mycobacterium tuberculosis strain by high doses of conventional chemotherapy, preserving liver function. J Cell Physiol 2020;235:1637-48. [PMID: 31283037 DOI: 10.1002/jcp.29082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
170 Trautwein C. Liver Regeneration. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 23-36. [DOI: 10.1016/b978-1-4160-3258-8.50007-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
171 Ding BS, Liu CH, Sun Y, Chen Y, Swendeman SL, Jung B, Chavez D, Cao Z, Christoffersen C, Nielsen LB. HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver. JCI Insight. 2016;1:e87058. [PMID: 28018969 DOI: 10.1172/jci.insight.87058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
172 Santoni-Rugiu E, Jelnes P, Thorgeirsson SS, Bisgaard HC. Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS. 2005;113:876-902. [PMID: 16480456 DOI: 10.1111/j.1600-0463.2005.apm_386.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 5.0] [Reference Citation Analysis]
173 Gong T, Zhang C, Ni X, Li X, Li J, Liu M, Zhan D, Xia X, Song L, Zhou Q, Ding C, Qin J, Wang Y. A time-resolved multi-omic atlas of the developing mouse liver. Genome Res 2020;30:263-75. [PMID: 32051188 DOI: 10.1101/gr.253328.119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
174 Khamphaya T, Chukijrungroat N, Saengsirisuwan V, Mitchell-Richards KA, Robert ME, Mennone A, Ananthanarayanan M, Nathanson MH, Weerachayaphorn J. Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor. Hepatology. 2018;67:560-574. [PMID: 29023819 DOI: 10.1002/hep.29588] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
175 Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, Decker A, Worley J, Caviglia JM, Yu L, Yin D, Saito Y, Savage T, Wells RG, Mack M, Zender L, Arpaia N, Remotti HE, Rabadan R, Sims P, Leblond AL, Weber A, Riener MO, Stockwell BR, Gaublomme J, Llovet JM, Kalluri R, Michalopoulos GK, Seki E, Sia D, Chen X, Califano A, Schwabe RF. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 2021;39:866-882.e11. [PMID: 33930309 DOI: 10.1016/j.ccell.2021.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
176 Lai AZ, Durrant M, Zuo D, Ratcliffe CD, Park M. Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer. J Biol Chem. 2012;287:8048-8059. [PMID: 22262855 DOI: 10.1074/jbc.M112.339820] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
177 Bai H, Jin W, Guo J, Ding Y, Chang C, Guo X, Song Y, Zhang J, Xu C. lncRNA Expression Reveals the Potential Regulatory Roles in Hepatocyte Proliferation during Rat Liver Regeneration. Biomed Res Int 2019;2019:8597953. [PMID: 31828136 DOI: 10.1155/2019/8597953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
178 Song S, Bi M. [Research progress of HGF/MET signaling pathway in EGFR-TKI resistance 
in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2014;17:755-9. [PMID: 25342043 DOI: 10.3779/j.issn.1009-3419.2014.10.08] [Reference Citation Analysis]
179 Matsumoto Y, Motoki T, Kubota S, Takigawa M, Tsubouchi H, Gohda E. Inhibition of tumor-stromal interaction through HGF/Met signaling by valproic acid. Biochem Biophys Res Commun 2008;366:110-6. [PMID: 18053801 DOI: 10.1016/j.bbrc.2007.11.089] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
180 Xu Q, Nakayama M, Suzuki Y, Sakai K, Nakamura T, Sakai Y, Matsumoto K. Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expression. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;302:G420-9. [DOI: 10.1152/ajpgi.00216.2011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
181 Descarpentries C, Leprêtre F, Escande F, Kherrouche Z, Figeac M, Sebda S, Baldacci S, Grégoire V, Jamme P, Copin MC, Tulasne D, Cortot AB. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients. J Thorac Oncol 2018;13:1873-83. [PMID: 30195702 DOI: 10.1016/j.jtho.2018.08.2023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
182 Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol. 2010;11:834-848. [PMID: 21102609 DOI: 10.1038/nrm3012] [Cited by in Crossref: 789] [Cited by in F6Publishing: 722] [Article Influence: 65.8] [Reference Citation Analysis]
183 Tatsukawa H, Kojima S. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. Cell Biol Int 2010;34:325-34. [DOI: 10.1042/cbi20090130] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
184 Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. Int J Mol Sci 2019;20:E4659. [PMID: 31546975 DOI: 10.3390/ijms20184659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
185 Gui Y, Yeganeh M, Ramanathan S, Leblanc C, Pomerleau V, Ferbeyre G, Saucier C, Ilangumaran S. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. J Hepatol 2011;55:1300-8. [PMID: 21703184 DOI: 10.1016/j.jhep.2011.03.027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
186 Jing L, Zong S, Li J, Ye M, Surhio MM, Yang L. Potential mechanism of protection effect of exopolysaccharide from Lachnum YM406 and its derivatives on carbon tetrachloride-induced acute liver injury in mice. Journal of Functional Foods 2017;36:203-14. [DOI: 10.1016/j.jff.2017.06.057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
187 Fafalios A, Ma J, Tan X, Stoops J, Luo J, Defrances MC, Zarnegar R. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med. 2011;17:1577-1584. [PMID: 22081023 DOI: 10.1038/nm.2531] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
188 Lee N, Lee J, Lee SH, Kim S, Kim S. Disproportionately high levels of HGF induce the degradation of the c-met receptor through the proteasomal degradation pathway. Biochem Biophys Res Commun 2018;505:925-30. [PMID: 30309648 DOI: 10.1016/j.bbrc.2018.09.127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
189 Farzaneh M, Rahimi F, Alishahi M, Khoshnam SE. Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes. Curr Stem Cell Res Ther 2019;14:9-13. [PMID: 30152289 DOI: 10.2174/1574888X13666180821160421] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
190 Martins GJ, Shahrokh M, Powell EM. Genetic disruption of Met signaling impairs GABAergic striatal development and cognition. Neuroscience 2011;176:199-209. [PMID: 21195751 DOI: 10.1016/j.neuroscience.2010.12.058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
191 Gelsomino F, Rossi G, Tiseo M. MET and Small-Cell Lung Cancer. Cancers (Basel) 2014;6:2100-15. [PMID: 25314153 DOI: 10.3390/cancers6042100] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
192 Fan Y, Bazai SK, Daian F, Arechederra M, Richelme S, Temiz NA, Yim A, Habermann BH, Dono R, Largaespada DA, Maina F. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis. Journal of Hepatology 2019;70:470-82. [DOI: 10.1016/j.jhep.2018.11.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
193 Tajima F, Tsuchiya H, Nishikawa K, Kataoka M, Hisatome I, Shiota G. Hepatocyte growth factor mobilizes and recruits hematopoietic progenitor cells into liver through a stem cell factor-mediated mechanism: Mobilization of hematopoietic progenitors by HGF. Hepatology Research 2010;40:711-9. [DOI: 10.1111/j.1872-034x.2010.00647.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
194 Jin C, Samuelson L, Cui C, Sun Y, Gerber DA. MAPK/ERK and Wnt/β-Catenin pathways are synergistically involved in proliferation of Sca-1 positive hepatic progenitor cells. Biochemical and Biophysical Research Communications 2011;409:803-7. [DOI: 10.1016/j.bbrc.2011.05.094] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
195 Kim S, Jung PY, Lee JS, Hwang S, Sohn JH, Yoon Y, Bae KS, Eom YW. Cultured human skeletal muscle satellite cells exhibit characteristics of mesenchymal stem cells and play anti-inflammatory roles through prostaglandin E2 and hepatocyte growth factors. Cell Biol Int 2021. [PMID: 34374483 DOI: 10.1002/cbin.11688] [Reference Citation Analysis]
196 Rudnick DA, Davidson NO. Functional Relationships between Lipid Metabolism and Liver Regeneration. Int J Hepatol 2012;2012:549241. [PMID: 22319652 DOI: 10.1155/2012/549241] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
197 Paranjpe S, Bowen WC, Mars WM, Orr A, Haynes MM, DeFrances MC, Liu S, Tseng GC, Tsagianni A, Michalopoulos GK. Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation. Hepatology 2016;64:1711-24. [PMID: 27397846 DOI: 10.1002/hep.28721] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
198 Graveel CR, Tolbert D, Vande Woude GF. MET: a critical player in tumorigenesis and therapeutic target. Cold Spring Harb Perspect Biol 2013;5:a009209. [PMID: 23818496 DOI: 10.1101/cshperspect.a009209] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 7.7] [Reference Citation Analysis]
199 Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2010;176:2-13. [PMID: 20019184 DOI: 10.2353/ajpath.2010.090675] [Cited by in Crossref: 457] [Cited by in F6Publishing: 434] [Article Influence: 35.2] [Reference Citation Analysis]
200 Fan Y, Richelme S, Avazeri E, Audebert S, Helmbacher F, Dono R, Maina F. Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis. PLoS Genet 2015;11:e1005533. [PMID: 26393505 DOI: 10.1371/journal.pgen.1005533] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
201 Attar MA, Salem JC, Pursel HS, Santy LC. CNK3 and IPCEF1 produce a single protein that is required for HGF dependent Arf6 activation and migration. Experimental Cell Research 2012;318:228-37. [DOI: 10.1016/j.yexcr.2011.10.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
202 Márquez-Coello M, Arizcorreta A, Rodríguez-Pardo M, Illanes-Álvarez F, Márquez D, Cuesta-Sancho S, Girón-González JA. Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs. Sci Rep 2021;11:9824. [PMID: 33972651 DOI: 10.1038/s41598-021-89370-6] [Reference Citation Analysis]
203 Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286-300. [PMID: 17559071 DOI: 10.1002/icp.21172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Sierra JR, Tsao MS. c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 2011;3:S21-35. [PMID: 22128285 DOI: 10.1177/1758834011422557] [Cited by in Crossref: 223] [Cited by in F6Publishing: 212] [Article Influence: 22.3] [Reference Citation Analysis]
205 Kherrouche Z, Monte D, Werkmeister E, Stoven L, De Launoit Y, Cortot AB, Tulasne D, Chotteau-Lelievre A. PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells. Mol Oncol 2015;9:1852-67. [PMID: 26238631 DOI: 10.1016/j.molonc.2015.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
206 Iwakiri T, Okumura M, Matsunaga N, Ichihara E, Shiotsuki S, Nagata M, Kumagai Y, Kai H, Arimori K. Hepatocyte growth factor increases uptake of estradiol 17β-d-glucuronide and Oatp1 protein level in rat hepatocytes. European Journal of Pharmacology 2008;580:19-26. [DOI: 10.1016/j.ejphar.2007.10.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
207 Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci. 2007;104:17081-17086. [PMID: 17940036 DOI: 10.1073/pnas.0704126104] [Cited by in Crossref: 216] [Cited by in F6Publishing: 203] [Article Influence: 14.4] [Reference Citation Analysis]
208 Hov H, Tian E, Holien T, Holt RU, Våtsveen TK, Fagerli UM, Waage A, Børset M, Sundan A. c-Met signaling promotes IL-6-induced myeloma cell proliferation. Eur J Haematol 2009;82:277-87. [PMID: 19187270 DOI: 10.1111/j.1600-0609.2009.01212.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
209 Tatsukawa H, Hitomi K. Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis. Cells 2021;10:1842. [PMID: 34360011 DOI: 10.3390/cells10071842] [Reference Citation Analysis]
210 Guo J, Tang Q. Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma. Cancer Gene Ther. 2021;. [PMID: 33500535 DOI: 10.1038/s41417-020-00259-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
211 Clemens MM, McGill MR, Apte U. Mechanisms and biomarkers of liver regeneration after drug-induced liver injury. Adv Pharmacol. 2019;85:241-262. [PMID: 31307589 DOI: 10.1016/bs.apha.2019.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
212 Cheng Z, Liu L, Zhang XJ, Lu M, Wang Y, Assfalg V, Laschinger M, von Figura G, Sunami Y, Michalski CW, Kleeff J, Friess H, Hartmann D, Hüser N. Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways. Sci Rep 2018;8:11894. [PMID: 30089804 DOI: 10.1038/s41598-018-30426-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
213 Seki E, Kondo Y, Iimuro Y, Naka T, Son G, Kishimoto T, Fujimoto J, Tsutsui H, Nakanishi K. Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. Journal of Hepatology 2008;48:237-45. [DOI: 10.1016/j.jhep.2007.08.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
214 Xu F, Hua C, Tautenhahn HM, Dirsch O, Dahmen U. The Role of Autophagy for the Regeneration of the Aging Liver. Int J Mol Sci 2020;21:E3606. [PMID: 32443776 DOI: 10.3390/ijms21103606] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
215 Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45-S53. [PMID: 16447274 DOI: 10.1002/hep.20969] [Cited by in Crossref: 1027] [Cited by in F6Publishing: 976] [Article Influence: 64.2] [Reference Citation Analysis]
216 Lv P, Yang Y, Wang Z. Recent Progress in the Development of Small Molecule c-Met Inhibitors. CTMC 2019;19:1276-88. [DOI: 10.2174/1568026619666190712205353] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
217 Schmeding M, Boas-Knoop S, Lippert S, Ruehl M, Somasundaram R, Dagdelen T, Neuhaus P, Neumann UP. Erythropoietin promotes hepatic regeneration after extended liver resection in rats. J Gastroenterol Hepatol 2008;23:1125-31. [PMID: 18086112 DOI: 10.1111/j.1440-1746.2007.05265.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
218 Wei Z, Doria C, Liu Y. Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol 2013;7:87-102. [PMID: 23761989 DOI: 10.4137/CMO.S7633] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
219 Chang CC, Hsieh TL, Tiong TY, Hsiao CH, Ji AT, Hsu WT, Lee OK, Ho JH. Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR. Biomaterials 2015;60:141-50. [PMID: 26000960 DOI: 10.1016/j.biomaterials.2015.04.058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
220 Striker G. HGF and extracellular matrix turnover in normal human glomeruli ex vivo. Kidney Int 2005;67:2500-1. [PMID: 15882298 DOI: 10.1111/j.1523-1755.2005.00367.x] [Reference Citation Analysis]
221 Mellado-Gil J, Rosa TC, Demirci C, Gonzalez-Pertusa JA, Velazquez-Garcia S, Ernst S, Valle S, Vasavada RC, Stewart AF, Alonso LC. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes. Diabetes. 2011;60:525-536. [PMID: 20980460 DOI: 10.2337/db09-1305] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 6.8] [Reference Citation Analysis]
222 Furchtgott LA, Chow CC, Periwal V. A model of liver regeneration. Biophys J 2009;96:3926-35. [PMID: 19450465 DOI: 10.1016/j.bpj.2009.01.061] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
223 Mazzone M, Comoglio PM. The Met pathway: master switch and drug target in cancer progression. FASEB J. 2006;20:1611-1621. [PMID: 16873884 DOI: 10.1096/fj.06-5947rev] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
224 Locatelli A, Lofgren KA, Daniel AR, Castro NE, Lange CA. Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression. Horm Cancer 2012;3:14-25. [PMID: 22124844 DOI: 10.1007/s12672-011-0097-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
225 Donthamsetty S, Mars WM, Orr A, Wu C, Michalopoulos GK. Protection against Fas-induced fulminant hepatic failure in liver specific integrin linked kinase knockout mice. Comp Hepatol 2011;10:11. [PMID: 22104495 DOI: 10.1186/1476-5926-10-11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
226 Berasain C, Avila MA. Regulation of hepatocyte identity and quiescence. Cell Mol Life Sci 2015;72:3831-51. [DOI: 10.1007/s00018-015-1970-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
227 Valdés-Arzate A, Luna A, Bucio L, Licona C, Clemens DL, Souza V, Hernandez E, Kershenobich D, Gutiérrez-Ruiz MC, Gómez-Quiroz LE. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic Biol Med. 2009;47:424-430. [PMID: 19463946 DOI: 10.1016/j.freeradbiomed.2009.05.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
228 Shaker ME, Ashamallah SA, El-mesery M. The novel c-Met inhibitor capmatinib mitigates diethylnitrosamine acute liver injury in mice. Toxicology Letters 2016;261:13-25. [DOI: 10.1016/j.toxlet.2016.08.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
229 Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011;26 Suppl 1:203-12. [PMID: 21199532 DOI: 10.1111/j.1440-1746.2010.06539.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 142] [Article Influence: 13.0] [Reference Citation Analysis]
230 Zhang YW. Promise and challenges on the horizon of MET-targeted cancer therapeutics. World J Biol Chem 2015; 6(2): 16-27 [PMID: 26009700 DOI: 10.4331/wjbc.v6.i2.16] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
231 Li Y, Wen X, Spataro BC, Hu K, Dai C, Liu Y. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. J Am Soc Nephrol. 2006;17:54-65. [PMID: 16291834 DOI: 10.1681/asn.2005030257] [Cited by in Crossref: 86] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
232 Gao W, Kim H, Ho M. Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells. PLoS One. 2015;10:e0137664. [PMID: 26332121 DOI: 10.1371/journal.pone.0137664] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
233 May BJ, Madoff DC. Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol. 2012;29:81-89. [PMID: 23729977 DOI: 10.1055/s-0032-1312568] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
234 McGill GG, Haq R, Nishimura EK, Fisher DE. c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem 2006;281:10365-73. [PMID: 16455654 DOI: 10.1074/jbc.M513094200] [Cited by in Crossref: 117] [Cited by in F6Publishing: 61] [Article Influence: 7.3] [Reference Citation Analysis]
235 Nowatari T, Fukunaga K, Ohkohchi N. Regulation of signal transduction and role of platelets in liver regeneration. Int J Hepatol 2012;2012:542479. [PMID: 22811921 DOI: 10.1155/2012/542479] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
236 Casaletto JB, Geddie ML, Abu-Yousif AO, Masson K, Fulgham A, Boudot A, Maiwald T, Kearns JD, Kohli N, Su S, Razlog M, Raue A, Kalra A, Håkansson M, Logan DT, Welin M, Chattopadhyay S, Harms BD, Nielsen UB, Schoeberl B, Lugovskoy AA, MacBeath G. MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM. Proc Natl Acad Sci U S A 2019;116:7533-42. [PMID: 30898885 DOI: 10.1073/pnas.1819085116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
237 Ali M, Payne SL. Biomaterial-based cell delivery strategies to promote liver regeneration. Biomater Res 2021;25:5. [PMID: 33632335 DOI: 10.1186/s40824-021-00206-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Matsumoto K, Yu S, Jia Y, Ahmed MR, Viswakarma N, Sarkar J, Kashireddy PV, Rao MS, Karpus W, Gonzalez FJ, Reddy JK. Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development. J Biol Chem 2007;282:17053-60. [PMID: 17438330 DOI: 10.1074/jbc.M701956200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
239 Mao SA, Glorioso JM, Nyberg SL. Liver regeneration. Transl Res. 2014;163:352-362. [PMID: 24495569 DOI: 10.1016/j.trsl.2014.01.005] [Cited by in Crossref: 112] [Cited by in F6Publishing: 108] [Article Influence: 14.0] [Reference Citation Analysis]
240 Zhu C, Li Y, Li W, Wu Q, Gao R. Gene transfer of c-met confers protection against D-galactosamine/lipopolysaccharide-induced acute liver failure. Dig Dis Sci 2012;57:925-34. [PMID: 22271415 DOI: 10.1007/s10620-012-2052-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
241 Weymann A, Hartman E, Gazit V, Wang C, Glauber M, Turmelle Y, Rudnick DA. p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology. 2009;50:207-215. [PMID: 19441104 DOI: 10.1002/hep.22979] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
242 Kurinna S, Barton MC. Hierarchies of transcriptional regulation during liver regeneration. Prog Mol Biol Transl Sci 2010;97:201-27. [PMID: 21074734 DOI: 10.1016/B978-0-12-385233-5.00007-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
243 Yamamoto H, Yun EJ, Gerber HP, Ferrara N, Whitsett JA, Vu TH. Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Dev Biol. 2007;308:44-53. [PMID: 17583691 DOI: 10.1016/j.ydbio.2007.04.042] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 7.4] [Reference Citation Analysis]
244 Almalé L, García-Álvaro M, Martínez-Palacián A, García-Bravo M, Lazcanoiturburu N, Addante A, Roncero C, Sanz J, de la O López M, Bragado P, Mikulits W, Factor VM, Thorgeirsson SS, Casal JI, Segovia JC, Rial E, Fabregat I, Herrera B, Sánchez A. c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition and Regulates Cell Phenotypic Switch. Stem Cells 2019;37:1108-18. [PMID: 31108004 DOI: 10.1002/stem.3038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
245 Jeon HM, Lee J. MET: roles in epithelial-mesenchymal transition and cancer stemness. Ann Transl Med 2017;5:5. [PMID: 28164090 DOI: 10.21037/atm.2016.12.67] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
246 Souza TM, Kleinjans JCS, Jennen DGJ. Dose and Time Dependencies in Stress Pathway Responses during Chemical Exposure: Novel Insights from Gene Regulatory Networks. Front Genet 2017;8:142. [PMID: 29085386 DOI: 10.3389/fgene.2017.00142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
247 Villeneuve J, Desmoulière A, Dewitte A, Bordeau N, Costet P, Bassaganyas L, Fricain JC, Ripoche J, Lepreux S. A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation. Mediators Inflamm 2017;2017:2982879. [PMID: 28785137 DOI: 10.1155/2017/2982879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
248 Nadanaka S, Kagiyama S, Kitagawa H. Roles of EXTL2, a member of the EXT family of tumour suppressors, in liver injury and regeneration processes. Biochem J 2013;454:133-45. [PMID: 23734945 DOI: 10.1042/BJ20130323] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
249 Cortot AB, Kherrouche Z, Descarpentries C, Wislez M, Baldacci S, Furlan A, Tulasne D. Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers. JNCI: Journal of the National Cancer Institute 2017;109. [DOI: 10.1093/jnci/djw262] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
250 Oliveira AG, Andrade VA, Guimarães ES, Florentino RM, Sousa PA, Marques PE, Melo FM, Ortega MJ, Menezes GB, Leite MF. Calcium signalling from the type I inositol 1,4,5-trisphosphate receptor is required at early phase of liver regeneration. Liver Int 2015;35:1162-71. [PMID: 24814243 DOI: 10.1111/liv.12587] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
251 Wang Y, Chen W, Han C, Zhang J, Song K, Kwon H, Dash S, Yao L, Wu T. Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury: Evidence for Smoothened-Mediated Activation of NF-κB/Epidermal Growth Factor Receptor/Akt in Hepatocytes that Counteract Fas-Induced Apoptosis. Am J Pathol 2018;188:2605-16. [PMID: 30366594 DOI: 10.1016/j.ajpath.2018.07.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
252 Knudsen BS, Vande Woude G. Showering c-MET-dependent cancers with drugs. Curr Opin Genet Dev 2008;18:87-96. [PMID: 18406132 DOI: 10.1016/j.gde.2008.02.001] [Cited by in Crossref: 109] [Cited by in F6Publishing: 105] [Article Influence: 7.8] [Reference Citation Analysis]
253 Ishibe S, Karihaloo A, Ma H, Zhang J, Marlier A, Mitobe M, Togawa A, Schmitt R, Czyczk J, Kashgarian M, Geller DS, Thorgeirsson SS, Cantley LG. Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology. Development 2009;136:337-45. [PMID: 19103805 DOI: 10.1242/dev.024463] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
254 Stella GM, Gentile A, Balderacchi A, Meloni F, Milan M, Benvenuti S. Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer. J Transl Med 2016;14:256. [PMID: 27590450 DOI: 10.1186/s12967-016-1008-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
255 Fernandes M, Jamme P, Cortot AB, Kherrouche Z, Tulasne D. When the MET receptor kicks in to resist targeted therapies. Oncogene 2021;40:4061-78. [PMID: 34031544 DOI: 10.1038/s41388-021-01835-0] [Reference Citation Analysis]
256 Berasain C, García-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, Avila MA. Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology. 2005;128:424-432. [PMID: 15685553 DOI: 10.1053/j.gastro.2004.11.006] [Cited by in Crossref: 128] [Cited by in F6Publishing: 118] [Article Influence: 7.5] [Reference Citation Analysis]
257 Chen GZ, Jiang HX, Lu ZF, Xiao J, Liang ZY, Qin SY. Bone marrow mesenchymal stem cells modulate cell proliferation and apoptosis and RohA expression in rat hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2010; 18(16): 1643-1649 [DOI: 10.11569/wcjd.v18.i16.1643] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
258 Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA. 2006;103:16834-16839. [PMID: 17053076 DOI: 10.1073/pnas.0605296103] [Cited by in Crossref: 280] [Cited by in F6Publishing: 277] [Article Influence: 17.5] [Reference Citation Analysis]
259 Sadler KC, Krahn KN, Gaur NA, Ukomadu C. Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1. Proc Natl Acad Sci USA. 2007;104:1570-1575. [PMID: 17242348 DOI: 10.1073/pnas.0610774104] [Cited by in Crossref: 114] [Cited by in F6Publishing: 110] [Article Influence: 7.6] [Reference Citation Analysis]
260 Lee JJX, Chan JJ, Choo SP. Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma. Diseases 2015;3:306-24. [PMID: 28943627 DOI: 10.3390/diseases3040306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
261 DiCara DM, Chirgadze DY, Pope AR, Karatt-Vellatt A, Winter A, Slavny P, van den Heuvel J, Parthiban K, Holland J, Packman LC, Mavria G, Hoffmann J, Birchmeier W, Gherardi E, McCafferty J. Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain. Sci Rep 2017;7:9000. [PMID: 28827556 DOI: 10.1038/s41598-017-09460-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
262 Ireton K. Entry of the bacterial pathogen Listeria monocytogenes into mammalian cells. Cell Microbiol 2007;9:1365-75. [PMID: 17419717 DOI: 10.1111/j.1462-5822.2007.00933.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 4.4] [Reference Citation Analysis]
263 Speicher T, Siegenthaler B, Bogorad RL, Ruppert R, Petzold T, Padrissa-Altes S, Bachofner M, Anderson DG, Koteliansky V, Fässler R, Werner S. Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling. Nat Commun 2014;5:3862. [PMID: 24844558 DOI: 10.1038/ncomms4862] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
264 Madonna R, Cevik C, Nasser M, De Caterina R. Hepatocyte growth factor: Molecular biomarker and player in cardioprotection and cardiovascular regeneration. Thromb Haemost 2017;107:656-61. [DOI: 10.1160/th11-10-0711] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 7.4] [Reference Citation Analysis]
265 Granito A, Guidetti E, Gramantieri L. c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma. J Hepatocell Carcinoma 2015;2:29-38. [PMID: 27508192 DOI: 10.2147/JHC.S77038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
266 Chan SL, Wong AM, Lee K, Wong N, Chan AK. Personalized therapy for hepatocellular carcinoma: Where are we now? Cancer Treatment Reviews 2016;45:77-86. [DOI: 10.1016/j.ctrv.2016.02.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
267 Ishikawa T, Factor VM, Marquardt JU, Raggi C, Seo D, Kitade M, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology. 2012;55:1215-1226. [PMID: 22095660 DOI: 10.1002/hep.24796] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 12.1] [Reference Citation Analysis]
268 Hiyoshi M, Konishi H, Uemura H, Matsuzaki H, Tsukamoto H, Sugimoto R, Takeda H, Dakeshita S, Kitayama A, Takami H, Sawachika F, Kido H, Arisawa K. d-Dopachrome tautomerase is a candidate for key proteins to protect the rat liver damaged by carbon tetrachloride. Toxicology 2009;255:6-14. [DOI: 10.1016/j.tox.2008.09.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
269 Koraishy FM, Silva C, Mason S, Wu D, Cantley LG. Hepatocyte growth factor (Hgf) stimulates low density lipoprotein receptor-related protein (Lrp) 5/6 phosphorylation and promotes canonical Wnt signaling. J Biol Chem 2014;289:14341-50. [PMID: 24692544 DOI: 10.1074/jbc.M114.563213] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
270 Zambelli A, Biamonti G, Amato A. HGF/c-Met Signalling in the Tumor Microenvironment. Adv Exp Med Biol 2021;1270:31-44. [PMID: 33123991 DOI: 10.1007/978-3-030-47189-7_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
271 Grossmann KS, Rosário M, Birchmeier C, Birchmeier W. The tyrosine phosphatase Shp2 in development and cancer. Adv Cancer Res 2010;106:53-89. [PMID: 20399956 DOI: 10.1016/S0065-230X(10)06002-1] [Cited by in Crossref: 163] [Cited by in F6Publishing: 107] [Article Influence: 13.6] [Reference Citation Analysis]
272 Zhou D, Tan RJ, Lin L, Zhou L, Liu Y. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int 2013;84:509-20. [PMID: 23715119 DOI: 10.1038/ki.2013.102] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 9.2] [Reference Citation Analysis]
273 Stöß C, Laschinger M, Wang B, Lu M, Altmayr F, Hartmann D, Hüser N, Holzmann B. TLR3 promotes hepatocyte proliferation after partial hepatectomy by stimulating uPA expression and the release of tissue-bound HGF. FASEB J 2020;34:10387-97. [PMID: 32539223 DOI: 10.1096/fj.202000904R] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
274 Pascale RM, Feo F, Calvisi DF. The complex role of bone morphogenetic protein 9 in liver damage and regeneration: New evidence from in vivo and in vitro studies. Liver Int. 2018;38:1547-1549. [PMID: 30145848 DOI: 10.1111/liv.13925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
275 Zhang F, Lu Y, Zheng S. Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis. Cell Signal. 2012;24:596-605. [PMID: 22108088 DOI: 10.1016/j.cellsig.2011.11.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
276 Jalili A, Shirvaikar N, Marquez-Curtis LA, Turner AR, Janowska-Wieczorek A. The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells. Stem Cells Dev 2010;19:1143-51. [PMID: 20021260 DOI: 10.1089/scd.2009.0376] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
277 Marona P, Górka J, Kotlinowski J, Majka M, Jura J, Miekus K. C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas. Cells 2019;8:E272. [PMID: 30909397 DOI: 10.3390/cells8030272] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
278 Tsagianni A, Mars WM, Bhushan B, Bowen WC, Orr A, Stoops J, Paranjpe S, Tseng GC, Liu S, Michalopoulos GK. Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal Mice. Am J Pathol 2018;188:2223-35. [PMID: 30031724 DOI: 10.1016/j.ajpath.2018.06.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
279 Palestino-Dominguez M, Pelaez-Luna M, Lazzarini-Lechuga R, Rodriguez-Ochoa I, Souza V, Miranda RU, Perez-Aguilar B, Bucio L, Marquardt JU, Gomez-Quiroz LE, Gutierrez-Ruiz MC. Recombinant human hepatocyte growth factor provides protective effects in cerulein-induced acute pancreatitis in mice. J Cell Physiol 2018;233:9354-64. [PMID: 29341114 DOI: 10.1002/jcp.26444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
280 Ido A, Moriuchi A, Numata M, Murayama T, Teramukai S, Marusawa H, Yamaji N, Setoyama H, Kim ID, Chiba T. Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety. J Transl Med. 2011;9:55. [PMID: 21548996 DOI: 10.1186/1479-5876-9-55] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
281 Huang J, Rudnick DA. Elucidating the metabolic regulation of liver regeneration. Am J Pathol. 2014;184:309-321. [PMID: 24139945 DOI: 10.1016/j.ajpath.2013.04.034] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 8.1] [Reference Citation Analysis]
282 Jangphattananont N, Sato H, Imamura R, Sakai K, Terakado Y, Murakami K, Barker N, Oshima H, Oshima M, Takagi J, Kato Y, Yano S, Matsumoto K. Distinct Localization of Mature HGF from its Precursor Form in Developing and Repairing the Stomach. Int J Mol Sci 2019;20:E2955. [PMID: 31212972 DOI: 10.3390/ijms20122955] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
283 Park KC, Richardson DR. The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents. Biochim Biophys Acta Gen Subj 2020;1864:129650. [PMID: 32522525 DOI: 10.1016/j.bbagen.2020.129650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
284 Kato T. Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals. Biomed Rep 2017;7:495-503. [PMID: 29188052 DOI: 10.3892/br.2017.1001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
285 Chan SL, Mok T, Ma BB. Management of hepatocellular carcinoma: beyond sorafenib. Curr Oncol Rep. 2012;14:257-266. [PMID: 22434314 DOI: 10.1007/s11912-11012-10233-11910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
286 Schwabe RF, Tabas I, Pajvani UB. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. Gastroenterology 2020;158:1913-28. [PMID: 32044315 DOI: 10.1053/j.gastro.2019.11.311] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 23.5] [Reference Citation Analysis]
287 Mohsin S, Shams S, Ali Nasir G, Khan M, Javaid Awan S, Khan SN, Riazuddin S. Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue. Differentiation. 2011;81:42-48. [PMID: 20943307 DOI: 10.1016/j.diff.2010.08.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
288 Takahara T, Xue F, Mazzone M, Yata Y, Nonome K, Kanayama M, Kawai K, Pisacane AM, Takahara S, Li X, Comoglio PM, Sugiyama T, Michieli P. Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology 2008;47:2010-25. [DOI: 10.1002/hep.22243] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
289 Tönges L, Ostendorf T, Lamballe F, Genestine M, Dono R, Koch JC, Bähr M, Maina F, Lingor P. Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivo. J Neurochem 2011;117:892-903. [PMID: 21443522 DOI: 10.1111/j.1471-4159.2011.07257.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
290 Smith JM, Xu J, Powell EM. Age dependent forebrain structural changes in mice deficient in the autism associated gene Met tyrosine kinase. Neuroimage Clin 2012;1:66-74. [PMID: 24179738 DOI: 10.1016/j.nicl.2012.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
291 Dai C, Huh CG, Thorgeirsson SS, Liu Y. Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am J Pathol. 2005;167:429-436. [PMID: 16049329 DOI: 10.1016/s0002-9440(10)62987-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
292 Tan Y, Xin X, Coffey FJ, Wiest DL, Dong LQ, Testa JR. Appl1 and Appl2 are Expendable for Mouse Development But Are Essential for HGF-Induced Akt Activation and Migration in Mouse Embryonic Fibroblasts. J Cell Physiol 2016;231:1142-50. [PMID: 26445298 DOI: 10.1002/jcp.25211] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
293 Tesfay L, Schulz VV, Frank SB, Lamb LE, Miranti CK. Receptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1. Mol Biol Cell 2016;27:2493-504. [PMID: 27307589 DOI: 10.1091/mbc.E15-09-0649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
294 Smyth EC, Sclafani F, Cunningham D. Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors. Onco Targets Ther 2014;7:1001-14. [PMID: 24959087 DOI: 10.2147/OTT.S44941] [Cited by in Crossref: 72] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
295 Matsumoto K, Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 2006;119:477-83. [PMID: 16453287 DOI: 10.1002/ijc.21808] [Cited by in Crossref: 159] [Cited by in F6Publishing: 138] [Article Influence: 9.9] [Reference Citation Analysis]
296 Moore RN, Moghe PV. Expedited growth factor-mediated specification of human embryonic stem cells toward the hepatic lineage. Stem Cell Res 2009;3:51-62. [PMID: 19497803 DOI: 10.1016/j.scr.2009.04.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
297 Mellado-Gil JM, Cobo-Vuilleumier N, Gauthier BR. Islet β-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest. J Transplant 2012;2012:230870. [PMID: 22919462 DOI: 10.1155/2012/230870] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
298 Sakai K, Aoki S, Matsumoto K. Hepatocyte growth factor and Met in drug discovery. J Biochem. 2015;157:271-284. [PMID: 25770121 DOI: 10.1093/jb/mvv027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
299 D'Alessandro R, Messa C, Refolo MG, Carr BI. Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC. Expert Opin Pharmacother 2015;16:2773-80. [PMID: 26479083 DOI: 10.1517/14656566.2015.1101065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
300 Christophi C, Harun N, Fifis T. Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors. J Gastrointest Surg. 2008;12:966-980. [PMID: 18181006 DOI: 10.1007/s11605-007-0459-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
301 Amaya MJ, Oliveira AG, Guimarães ES, Casteluber MC, Carvalho SM, Andrade LM, Pinto MC, Mennone A, Oliveira CA, Resende RR, Menezes GB, Nathanson MH, Leite MF. The insulin receptor translocates to the nucleus to regulate cell proliferation in liver. Hepatology 2014;59:274-83. [PMID: 23839970 DOI: 10.1002/hep.26609] [Cited by in F6Publishing: 39] [Reference Citation Analysis]
302 Moumen A, Patané S, Porras A, Dono R, Maina F. Met acts on Mdm2 via mTOR to signal cell survival during development. Development 2007;134:1443-51. [PMID: 17329361 DOI: 10.1242/dev.02820] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
303 Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer HA, McNaughton K, Miller SM, Chhetri RK, Oldenburg AL, Fleming JM, Amos KD, Makowski L, Troester MA. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res 2013;15:R82. [PMID: 24025166 DOI: 10.1186/bcr3476] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
304 Modica C, Tortarolo D, Comoglio PM, Basilico C, Vigna E. MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk. Int J Mol Sci 2018;19:E3920. [PMID: 30544501 DOI: 10.3390/ijms19123920] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
305 Sarkar A, Saha S, Paul A, Maji A, Roy P, Maity TK. Understanding stem cells and its pivotal role in regenerative medicine. Life Sci 2021;273:119270. [PMID: 33640402 DOI: 10.1016/j.lfs.2021.119270] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
306 Moumen A, Ieraci A, Patané S, Solé C, Comella JX, Dono R, Maina F. Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner. Hepatology. 2007;45:1210-1217. [PMID: 17464994 DOI: 10.1002/hep.21604] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
307 Addante A, Roncero C, Almalé L, Lazcanoiturburu N, García-Álvaro M, Fernández M, Sanz J, Hammad S, Nwosu ZC, Lee SJ, Fabregat I, Dooley S, Ten Dijke P, Herrera B, Sánchez A. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury. Liver Int 2018;38:1664-75. [PMID: 29751359 DOI: 10.1111/liv.13879] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
308 Hayata D, Fukuta K, Matsumoto K, Adachi E, Hanada K, Adachi K, Nakamura T. Generation of engineered recombinant hepatocyte growth factor cleaved and activated by Genenase I. Journal of Biotechnology 2008;133:478-85. [DOI: 10.1016/j.jbiotec.2007.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
309 Du SS, Zeng ZC, Tang ZY, Zhang ZY, Shi LS, Wu Z, Qiang M, Liu ZS. Regenerative capacity of normal and irradiated liver following partial hepatectomy in rats. Int J Radiat Biol 2009;85:1114-25. [PMID: 19995237 DOI: 10.3109/09553000903242115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
310 Peschard P, Park M. From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 2007;26:1276-85. [PMID: 17322912 DOI: 10.1038/sj.onc.1210201] [Cited by in Crossref: 129] [Cited by in F6Publishing: 118] [Article Influence: 8.6] [Reference Citation Analysis]
311 Ma X, Qiu S. Control of cortical synapse development and plasticity by MET receptor tyrosine kinase, a genetic risk factor for autism. J Neurosci Res 2020;98:2115-29. [PMID: 31746037 DOI: 10.1002/jnr.24542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
312 Beyer TA, Xu W, Teupser D, auf dem Keller U, Bugnon P, Hildt E, Thiery J, Kan YW, Werner S. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J 2008;27:212-23. [PMID: 18059474 DOI: 10.1038/sj.emboj.7601950] [Cited by in Crossref: 179] [Cited by in F6Publishing: 179] [Article Influence: 11.9] [Reference Citation Analysis]
313 Peng Y, Huentelman M, Smith C, Qiu S. MET receptor tyrosine kinase as an autism genetic risk factor. Int Rev Neurobiol 2013;113:135-65. [PMID: 24290385 DOI: 10.1016/B978-0-12-418700-9.00005-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
314 Milkiewicz KL, Aimone LD, Albom MS, Angeles TS, Chang H, Grobelny JV, Husten J, Losardo C, Miknyoczki S, Murthy S, Rolon-steele D, Underiner TL, Weinberg LR, Worrell CS, Zeigler KS, Dorsey BD. Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group. Bioorganic & Medicinal Chemistry 2011;19:6274-84. [DOI: 10.1016/j.bmc.2011.09.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
315 Bachofner M, Speicher T, Bogorad RL, Muzumdar S, Derrer CP, Hürlimann F, Böhm F, Nanni P, Kockmann T, Kachaylo E, Meyer M, Padrissa-Altés S, Graf R, Anderson DG, Koteliansky V, Auf dem Keller U, Werner S. Large-Scale Quantitative Proteomics Identifies the Ubiquitin Ligase Nedd4-1 as an Essential Regulator of Liver Regeneration. Dev Cell 2017;42:616-625.e8. [PMID: 28890072 DOI: 10.1016/j.devcel.2017.07.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
316 Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology. 2009;137:297-308, 308.e1-4. [PMID: 19208365 DOI: 10.1053/j.gastro.2009.01.068] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.2] [Reference Citation Analysis]
317 Chan SL, Chan AW, Yeo W. Novel therapeutic targets and predictive markers for hepatocellular carcinoma. Expert Opinion on Therapeutic Targets 2015;19:973-83. [DOI: 10.1517/14728222.2015.1031109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
318 Park H, Kim D, Son E, Shin S, Sa JK, Kim S, Yoon Y, Nam D. Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody. Biochemical and Biophysical Research Communications 2017;494:409-15. [DOI: 10.1016/j.bbrc.2017.09.061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
319 Bangru S, Kalsotra A. Cellular and molecular basis of liver regeneration. Semin Cell Dev Biol 2020;100:74-87. [PMID: 31980376 DOI: 10.1016/j.semcdb.2019.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
320 Liu Z, Li Q, Shen R, Ci L, Wan Z, Shi J, Huang Q, Yang X, Zhang M, Yang H, Sun R, Wang Z, Huang F, Lu T, Fei J. Betaine/GABA transporter-1 (BGT-1) deficiency in mouse prevents acute liver failure in vivo and hepatocytes apoptosis in vitro. Biochim Biophys Acta Mol Basis Dis 2020;1866:165634. [PMID: 31830527 DOI: 10.1016/j.bbadis.2019.165634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
321 Lüdtke TH, Christoffels VM, Petry M, Kispert A. Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation. Hepatology. 2009;49:969-978. [PMID: 19140222 DOI: 10.1002/hep.22700] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
322 Zhang S, Hou Y, Yang J, Xie D, Jiang L, Hu H, Hu J, Luo C, Zhang Q. Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure. J Cell Mol Med 2020;24:7082-93. [PMID: 32492261 DOI: 10.1111/jcmm.15290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
323 Judson MC, Eagleson KL, Wang L, Levitt P. Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain. J Comp Neurol 2010;518:4463-78. [PMID: 20853516 DOI: 10.1002/cne.22467] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
324 Ringelhan M, Schmid RM, Geisler F. The NF-κB subunit RelA/p65 is dispensable for successful liver regeneration after partial hepatectomy in mice. PLoS One. 2012;7:e46469. [PMID: 23049704 DOI: 10.1371/journal.pone.0046469] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
325 Ueno M, Lee LK, Chhabra A, Kim YJ, Sasidharan R, Van Handel B, Wang Y, Kamata M, Kamran P, Sereti KI, Ardehali R, Jiang M, Mikkola HK. c-Met-dependent multipotent labyrinth trophoblast progenitors establish placental exchange interface. Dev Cell 2013;27:373-86. [PMID: 24286824 DOI: 10.1016/j.devcel.2013.10.019] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
326 Tulasne D, Foveau B. The shadow of death on the MET tyrosine kinase receptor. Cell Death Differ 2008;15:427-34. [DOI: 10.1038/sj.cdd.4402229] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
327 Wen X, Li Y, Hu K, Dai C, Liu Y. Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol 2005;167:947-57. [PMID: 16192631 DOI: 10.1016/S0002-9440(10)61185-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
328 Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K, Miyazaki J, Nakamura T, Yamamoto K. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 2005;175:4745-53. [PMID: 16177122 DOI: 10.4049/jimmunol.175.7.4745] [Cited by in Crossref: 163] [Cited by in F6Publishing: 155] [Article Influence: 9.6] [Reference Citation Analysis]
329 Chan SL, Mok T, Ma BB. Management of hepatocellular carcinoma: beyond sorafenib. Curr Oncol Rep. 2012;14:257-266. [PMID: 22434314 DOI: 10.1007/s11912-012-0233-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
330 Tamamouna V, Panagi M, Theophanous A, Demosthenous M, Michail M, Papadopoulou M, Teloni S, Pitsouli C, Apidianakis Y. Evidence of two types of balance between stem cell mitosis and enterocyte nucleus growth in the Drosophila midgut. Development 2020;147:dev189472. [PMID: 32513656 DOI: 10.1242/dev.189472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
331 Gao C, Vande Woude GF. The MET Receptor Family. In: Wheeler DL, Yarden Y, editors. Receptor Tyrosine Kinases: Family and Subfamilies. Cham: Springer International Publishing; 2015. pp. 321-58. [DOI: 10.1007/978-3-319-11888-8_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
332 Chung SI, Seong J, Park YN, Kim WW, Oh HJ, Han KH. Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats. J Radiat Res 2010;51:643-50. [PMID: 21116097 DOI: 10.1269/jrr.09114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
333 Miyazawa M, Torii T, Toshimitsu Y, Koyama I. Effect of Mechanical Stress Imposition on Co-culture of Hepatic Parenchymal and Nonparenchymal Cells: Possibility of Stimulating Production of Regenerating Factor. Transplantation Proceedings 2005;37:2398-401. [DOI: 10.1016/j.transproceed.2005.03.103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
334 Li Z, Mizuno S, Nakamura T. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007;292:G639-46. [DOI: 10.1152/ajpgi.00292.2006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
335 Ross J, Gherardi E, Mallorqui-Fernandez N, Bocci M, Sobkowicz A, Rees M, Rowe A, Ellmerich S, Massie I, Soeda J, Selden C, Hodgson H. Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver. Gastroenterology 2012;142:897-906. [PMID: 22178588 DOI: 10.1053/j.gastro.2011.12.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
336 Pelosof LC, Davis PH, Zhang Z, Zhang X, Stanley SL Jr. Co-ordinate but disproportionate activation of apoptotic, regenerative and inflammatory pathways characterizes the liver response to acute amebic infection. Cell Microbiol 2006;8:508-22. [PMID: 16469061 DOI: 10.1111/j.1462-5822.2005.00642.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
337 Sangwan V, Paliouras GN, Cheng A, Dubé N, Tremblay ML, Park M. Protein-tyrosine Phosphatase 1B Deficiency Protects against Fas-induced Hepatic Failure. Journal of Biological Chemistry 2006;281:221-8. [DOI: 10.1074/jbc.m507858200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
338 Li Z, Chen J, Li L, Ran JH, Li XH, Liu ZH, Liu GJ, Gao YC, Zhang XL, Sun HD. Human hepatocyte growth factor (hHGF)-modified hepatic oval cells improve liver transplant survival. PLoS One. 2012;7:e44805. [PMID: 23028627 DOI: 10.1371/journal.pone.0044805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
339 Cecchi F, Rabe DC, Bottaro DP. The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer. Curr Signal Transduct Ther 2011;6:146-51. [PMID: 25197268 DOI: 10.2174/157436211795659955] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
340 Kaposi-Novak P, Lee JS, Gòmez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest. 2006;116:1582-1595. [PMID: 16710476 DOI: 10.1172/jci27236] [Cited by in Crossref: 268] [Cited by in F6Publishing: 164] [Article Influence: 16.8] [Reference Citation Analysis]
341 Niemann HH. Structural insights into Met receptor activation. Eur J Cell Biol 2011;90:972-81. [PMID: 21242015 DOI: 10.1016/j.ejcb.2010.11.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
342 Cai Z, Wei D, Schroeder GM, Cornelius LA, Kim K, Chen X, Schmidt RJ, Williams DK, Tokarski JS, An Y, Sack JS, Manne V, Kamath A, Zhang Y, Marathe P, Hunt JT, Lombardo LJ, Fargnoli J, Borzilleri RM. Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 2008;18:3224-9. [DOI: 10.1016/j.bmcl.2008.04.047] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
343 Ho C, Lee P, Lai Y, Hu R, Ho M, Wu Y. Gene Expression Profiles in Living Donors Immediately After Partial Hepatectomy—The Initial Response of Liver Regeneration. Journal of the Formosan Medical Association 2007;106:288-94. [DOI: 10.1016/s0929-6646(09)60254-0] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
344 Li J, Campbell JS, Mitchell C, McMahan RS, Yu X, Riehle KJ, Bumgarner RE, Fausto N. Relationships between deficits in tissue mass and transcriptional programs after partial hepatectomy in mice. Am J Pathol 2009;175:947-57. [PMID: 19700759 DOI: 10.2353/ajpath.2009.090043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
345 Finisguerra V, Prenen H, Mazzone M. Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma. Oncogene 2016;35:5457-67. [PMID: 26996670 DOI: 10.1038/onc.2016.36] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
346 Su M, Hu R, Song Y, Liu Y, Lai L. Targeted deletion of c-Met in thymic epithelial cells leads to an autoimmune phenotype. Immunol Cell Biol 2018;96:229-35. [PMID: 29363160 DOI: 10.1111/imcb.1026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
347 Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev. 2008;27:85-94. [PMID: 18175071 DOI: 10.1007/s10555-007-9107-6] [Cited by in Crossref: 221] [Cited by in F6Publishing: 211] [Article Influence: 15.8] [Reference Citation Analysis]
348 Caballero J, Quiliano M, Alzate-Morales JH, Zimic M, Deharo E. Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors. J Comput Aided Mol Des 2011;25:349-69. [PMID: 21487786 DOI: 10.1007/s10822-011-9425-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
349 Ilangumaran S, Villalobos-hernandez A, Bobbala D, Ramanathan S. The hepatocyte growth factor (HGF)–MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions. Cytokine 2016;82:125-39. [DOI: 10.1016/j.cyto.2015.12.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
350 Klotz DM, Link T, Wimberger P, Kuhlmann JD. Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer. Mol Oncol 2021. [PMID: 33738970 DOI: 10.1002/1878-0261.12949] [Reference Citation Analysis]
351 Garner OB, Bush KT, Nigam KB, Yamaguchi Y, Xu D, Esko JD, Nigam SK. Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. Dev Biol. 2011;355:394-403. [PMID: 21586278 DOI: 10.1016/j.ydbio.2011.04.035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
352 Lai AZ, Abella JV, Park M. Crosstalk in Met receptor oncogenesis. Trends Cell Biol. 2009;19:542-551. [PMID: 19758803 DOI: 10.1016/j.tcb.2009.07.002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 136] [Article Influence: 10.8] [Reference Citation Analysis]
353 Chmielowiec J, Borowiak M, Morkel M, Stradal T, Munz B, Werner S, Wehland J, Birchmeier C, Birchmeier W. c-Met is essential for wound healing in the skin. J Cell Biol 2007;177:151-62. [PMID: 17403932 DOI: 10.1083/jcb.200701086] [Cited by in Crossref: 212] [Cited by in F6Publishing: 213] [Article Influence: 14.1] [Reference Citation Analysis]
354 Youles M, Holmes O, Petoukhov MV, Nessen MA, Stivala S, Svergun DI, Gherardi E. Engineering the NK1 fragment of hepatocyte growth factor/scatter factor as a MET receptor antagonist. J Mol Biol 2008;377:616-22. [PMID: 18291418 DOI: 10.1016/j.jmb.2008.01.034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
355 Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286-300. [PMID: 17559071 DOI: 10.1002/jcp.21172] [Cited by in Crossref: 968] [Cited by in F6Publishing: 908] [Article Influence: 69.1] [Reference Citation Analysis]
356 Golonko A, Lewandowska H, Świsłocka R, Jasińska U, Priebe W, Lewandowski W. Curcumin as tyrosine kinase inhibitor in cancer treatment. European Journal of Medicinal Chemistry 2019;181:111512. [DOI: 10.1016/j.ejmech.2019.07.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
357 Cui JJ. Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress. J Med Chem 2014;57:4427-53. [PMID: 24320965 DOI: 10.1021/jm401427c] [Cited by in Crossref: 133] [Cited by in F6Publishing: 123] [Article Influence: 14.8] [Reference Citation Analysis]
358 Norris CA, He M, Kang LI, Ding MQ, Radder JE, Haynes MM, Yang Y, Paranjpe S, Bowen WC, Orr A, Michalopoulos GK, Stolz DB, Mars WM. Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli. PLoS One 2014;9:e96053. [PMID: 24763697 DOI: 10.1371/journal.pone.0096053] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
359 Ono T, Tsuji T, Sakai M, Yukizaki C, Ino H, Akagi I, Hiramatsu K, Matsumoto Y, Sugiura Y, Uto H, Tsubouchi H, Gohda E. Induction of hepatocyte growth factor production in human dermal fibroblasts and their proliferation by the extract of bitter melon pulp. Cytokine 2009;46:119-26. [DOI: 10.1016/j.cyto.2008.12.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
360 Murtha-Lemekhova A, Fuchs J, Ghamarnejad O, Nikdad M, Probst P, Hoffmann K. Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis. Sci Rep 2021;11:13739. [PMID: 34215781 DOI: 10.1038/s41598-021-92888-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
361 Chen Y, Xu Z, Zeng Y, Liu J, Wang X, Kang Y. Altered metabolism by autophagy defection affect liver regeneration. PLoS One 2021;16:e0250578. [PMID: 33914811 DOI: 10.1371/journal.pone.0250578] [Reference Citation Analysis]
362 Della-Fazia MA, Castelli M, Piobbico D, Pieroni S, Servillo G. The Ins and Outs of HOPS/TMUB1 in biology and pathology. FEBS J 2021;288:2773-83. [PMID: 32860479 DOI: 10.1111/febs.15539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
363 Weiskirchen R, Mahli A, Weiskirchen S, Hellerbrand C. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Front Physiol 2015;6:140. [PMID: 25999863 DOI: 10.3389/fphys.2015.00140] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
364 Chan SL, Yeo W. Development of systemic therapy for hepatocellular carcinoma at 2013: Updates and insights. World J Gastroenterol 2014; 20(12): 3135-3145 [PMID: 24696599 DOI: 10.3748/wjg.v20.i12.3135] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
365 Wang X, Kery R, Xiong Q. Synaptopathology in autism spectrum disorders: Complex effects of synaptic genes on neural circuits. Prog Neuropsychopharmacol Biol Psychiatry 2018;84:398-415. [PMID: 28986278 DOI: 10.1016/j.pnpbp.2017.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
366 Jia C. Advances in the regulation of liver regeneration. Expert Review of Gastroenterology & Hepatology 2014;5:105-21. [DOI: 10.1586/egh.10.87] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 6.4] [Reference Citation Analysis]
367 Hu Y, Zhang X, Zhao Z, Chen X, Zhou Z, Yang X, Yang B, He Q, Luo P. Keratinocytes apoptosis contributes to crizotinib induced-erythroderma. Toxicology Letters 2020;319:102-10. [DOI: 10.1016/j.toxlet.2019.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
368 Ghanim AMH, Younis NS, Metwaly HA. Vanillin augments liver regeneration effectively in Thioacetamide induced liver fibrosis rat model. Life Sci 2021;286:120036. [PMID: 34637793 DOI: 10.1016/j.lfs.2021.120036] [Reference Citation Analysis]
369 Martínez-Palacián A, del Castillo G, Suárez-Causado A, García-Álvaro M, de Morena-Frutos D, Fernández M, Roncero C, Fabregat I, Herrera B, Sánchez A. Mouse hepatic oval cells require Met-dependent PI3K to impair TGF-β-induced oxidative stress and apoptosis. PLoS One. 2013;8:e53108. [PMID: 23301029 DOI: 10.1371/journal.pone.0053108] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
370 Tan Q, Hu J, Yu X, Guan W, Lu H, Yu Y, Yu Y, Zang G, Tang Z. The Role of IL-1 Family Members and Kupffer Cells in Liver Regeneration. Biomed Res Int 2016;2016:6495793. [PMID: 27092311 DOI: 10.1155/2016/6495793] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
371 Thompson SM, Jondal DE, Butters KA, Knudsen BE, Anderson JL, Stokes MP, Jia X, Grande JP, Roberts LR, Callstrom MR, Woodrum DA. Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma. Int J Hyperthermia 2018;34:812-23. [PMID: 28954551 DOI: 10.1080/02656736.2017.1385859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
372 Su D, Singer EA, Srinivasan R. Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology. Current Opinion in Oncology 2015;27:217-23. [DOI: 10.1097/cco.0000000000000186] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 4.9] [Reference Citation Analysis]
373 Favier RP, Spee B, Penning LC, Rothuizen J. Copper-induced hepatitis: the COMMD1 deficient dog as a translational animal model for human chronic hepatitis. Vet Q 2011;31:49-60. [PMID: 22029820 DOI: 10.1080/01652176.2011.563146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
374 Khan AZ, Mudan SS. Liver regeneration: mechanisms, mysteries and more. ANZ J Surg. 2007;77:9-14. [PMID: 17295811 DOI: 10.1111/j.1445-2197.2006.03981.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
375 Wang K, Li Y, Zhu T, Zhang Y, Li W, Lin W, Li J, Zhu C. Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure. Stem Cell Res Ther 2017;8:162. [PMID: 28679425 DOI: 10.1186/s13287-017-0614-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
376 Jiang Y, Zhang K, Gao S, Wang G, Huang J, Wang J, Chen L. Discovery of Potent c-MET Inhibitors with New Scaffold Having Different Quinazoline, Pyridine and Tetrahydro-Pyridothienopyrimidine Headgroups. Molecules 2016;21:E612. [PMID: 27187326 DOI: 10.3390/molecules21050612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
377 You H, Ding W, Dang H, Jiang Y, Rountree CB. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology. 2011;54:879-889. [PMID: 21618573 DOI: 10.1002/hep.24450] [Cited by in Crossref: 123] [Cited by in F6Publishing: 137] [Article Influence: 11.2] [Reference Citation Analysis]
378 Liu J, Pan G, Liang T, Huang P. HGF/c-Met signaling mediated mesenchymal stem cell-induced liver recovery in intestinal ischemia reperfusion model. Int J Med Sci. 2014;11:626-633. [PMID: 24782653 DOI: 10.7150/ijms.8228] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
379 del Castillo G, Factor VM, Fernández M, Alvarez-Barrientos A, Fabregat I, Thorgeirsson SS, Sánchez A. Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro. Am J Pathol 2008;172:1238-47. [PMID: 18385520 DOI: 10.2353/ajpath.2008.070793] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
380 McKinnon H, Gherardi E, Reidy M, Bowyer D. Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis. Am J Pathol. 2006;168:340-348. [PMID: 16400035 DOI: 10.2353/ajpath.2006.050379] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
381 Avetisyan M, Wang H, Schill EM, Bery S, Grider JR, Hassell JA, Stappenbeck T, Heuckeroth RO. Hepatocyte Growth Factor and MET Support Mouse Enteric Nervous System Development, the Peristaltic Response, and Intestinal Epithelial Proliferation in Response to Injury. J Neurosci 2015;35:11543-58. [PMID: 26290232 DOI: 10.1523/JNEUROSCI.5267-14.2015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
382 Pacchiana G, Chiriaco C, Stella MC, Petronzelli F, De Santis R, Galluzzo M, Carminati P, Comoglio PM, Michieli P, Vigna E. Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody. J Biol Chem. 2010;285:36149-36157. [PMID: 20833723 DOI: 10.1074/jbc.m110.134031] [Cited by in Crossref: 63] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
383 Harun N, Costa P, Christophi C. Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met. Clin Exp Metastasis 2014;31:1-14. [PMID: 23900501 DOI: 10.1007/s10585-013-9604-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
384 Marquardt JU, Thorgeirsson SS. Linking MLL and the HGF-MET signaling pathway in liver cancer. J Clin Invest 2013;123:2780-3. [PMID: 23934122 DOI: 10.1172/JCI70235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
385 He ZY, Lou KH, Zhao JH, Zhang M, Zhang LC, Li J, Yu HF, Zhang RP, Wei-Yan H. Resina Draconis Reduces Acute Liver Injury and Promotes Liver Regeneration after 2/3 Partial Hepatectomy in Mice. Evid Based Complement Alternat Med 2020;2020:2305784. [PMID: 33082819 DOI: 10.1155/2020/2305784] [Reference Citation Analysis]
386 Hsu YC, Huang HP, Yu IS, Su KY, Lin SR, Lin WC, Wu HL, Shi GY, Tao MH, Kao CH, Wu YM, Martin PE, Lin SY, Yang PC, Lin SW. Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice. Hepatology 2012;56:1913-23. [PMID: 22505209 DOI: 10.1002/hep.25773] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
387 Judson MC, Bergman MY, Campbell DB, Eagleson KL, Levitt P. Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol 2009;513:511-31. [PMID: 19226509 DOI: 10.1002/cne.21969] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
388 Giebeler A, Brandenburg L, Kaldenbach M, Erschfeld S, Wasmuth H, Wruck C, Trautwein C, Streetz KL. Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation. Lab Invest 2012;92:1726-37. [DOI: 10.1038/labinvest.2012.122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
389 Tang Q, Wang L, Duan Y, Wang W, Huang S, Zhi J, Jia S, Zhu W, Wang P, Luo R, Zheng P. Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors. European Journal of Medicinal Chemistry 2017;133:97-106. [DOI: 10.1016/j.ejmech.2017.03.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
390 Strnad P, Omary MB. Transglutaminase cross-links Sp1-mediated transcription to ethanol-induced liver injury. Gastroenterology 2009;136:1502-5. [PMID: 19318103 DOI: 10.1053/j.gastro.2009.03.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
391 Qiang J, Tao F, Bao W, He J, Li X, Chen J, Xu P. Responses of functional miRNA-mRNA regulatory modules to a high-fat diet in the liver of hybrid yellow catfish (Pelteobagrus fulvidraco × P. vachelli). Genomics 2021;113:1207-20. [PMID: 33309769 DOI: 10.1016/j.ygeno.2020.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
392 Liu J, Cheng X, Guo Z, Wang Z, Li D, Kang F, Li H, Li B, Cao Z, Nassal M. Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis. PLoS One. 2013;8:e53392. [PMID: 23301066 DOI: 10.1371/journal.pone.0053392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
393 Sydor S, Gu Y, Schlattjan M, Bechmann LP, Rauen U, Best J, Paul A, Baba HA, Sowa JP, Gerken G. Steatosis does not impair liver regeneration after partial hepatectomy. Lab Invest. 2013;93:20-30. [PMID: 23069937 DOI: 10.1038/labinvest.2012.142] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
394 Saleh M, Taher M, Sohrabpour AA, Vaezi AA, Nasiri Toosi M, Kavianpour M, Ghazvinian Z, Abdolahi S, Verdi J. Perspective of placenta derived mesenchymal stem cells in acute liver failure. Cell Biosci 2020;10:71. [PMID: 32483484 DOI: 10.1186/s13578-020-00433-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
395 Nadanaka S, Kitagawa H. EXTL2 controls liver regeneration and aortic calcification through xylose kinase-dependent regulation of glycosaminoglycan biosynthesis. Matrix Biol 2014;35:18-24. [PMID: 24176719 DOI: 10.1016/j.matbio.2013.10.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
396 Qi B, Mi B, Zhai X, Xu Z, Zhang X, Tian Z, Gong P. Discovery and optimization of novel 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazones as c-Met kinase inhibitors. Bioorg Med Chem 2013;21:5246-60. [PMID: 23838381 DOI: 10.1016/j.bmc.2013.06.026] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
397 van de Sand C, Horstmann S, Schmidt A, Sturm A, Bolte S, Krueger A, Lütgehetmann M, Pollok JM, Libert C, Heussler VT. The liver stage of Plasmodium berghei inhibits host cell apoptosis. Mol Microbiol 2005;58:731-42. [PMID: 16238623 DOI: 10.1111/j.1365-2958.2005.04888.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 7.4] [Reference Citation Analysis]
398 Maher JJ. Pathogenesis of NAFLD and NASH. In: Chalasani N, Szabo G, editors. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing; 2016. pp. 71-101. [DOI: 10.1007/978-3-319-20538-0_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
399 Taki-Eldin A, Zhou L, Xie HY, Zheng SS. Liver regeneration after liver transplantation. Eur Surg Res. 2012;48:139-153. [PMID: 22572792 DOI: 10.1159/000337865] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
400 Yu J, Zhang L, Peng J, Ward R, Hao P, Wang J, Zhang N, Yang Y, Guo X, Xiang C, An S, Xu TR. Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways. Biochem Pharmacol 2022;195:114864. [PMID: 34861243 DOI: 10.1016/j.bcp.2021.114864] [Reference Citation Analysis]
401 Niendorf S, Oksche A, Kisser A, Löhler J, Prinz M, Schorle H, Feller S, Lewitzky M, Horak I, Knobeloch KP. Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol Cell Biol 2007;27:5029-39. [PMID: 17452457 DOI: 10.1128/MCB.01566-06] [Cited by in Crossref: 135] [Cited by in F6Publishing: 85] [Article Influence: 9.0] [Reference Citation Analysis]
402 Saad KM, Shaker ME, Shaaban AA, Abdelrahman RS, Said E. The c-Met inhibitor capmatinib alleviates acetaminophen-induced hepatotoxicity. Int Immunopharmacol 2020;81:106292. [PMID: 32062076 DOI: 10.1016/j.intimp.2020.106292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
403 Tang S, Powell EM, Zhu W, Lo FS, Erzurumlu RS, Xu S. Altered Forebrain Functional Connectivity and Neurotransmission in a Kinase-Inactive Met Mouse Model of Autism. Mol Imaging 2019;18:1536012118821034. [PMID: 30799683 DOI: 10.1177/1536012118821034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
404 Piater B, Doerner A, Guenther R, Kolmar H, Hock B. Aptamers Binding to c-Met Inhibiting Tumor Cell Migration. PLoS One 2015;10:e0142412. [PMID: 26658271 DOI: 10.1371/journal.pone.0142412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
405 Nisa L, Aebersold DM, Giger R, Zimmer Y, Medová M. Biological, diagnostic and therapeutic relevance of the MET receptor signaling in head and neck cancer. Pharmacology & Therapeutics 2014;143:337-49. [DOI: 10.1016/j.pharmthera.2014.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
406 Fernandes M, Duplaquet L, Tulasne D. Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase. BMB Rep 2019;52:239-49. [PMID: 30670153 [PMID: 30670153 DOI: 10.5483/bmbrep.2019.52.4.024] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
407 Liu J, Nie M, Wang Y, Hu J, Zhang F, Gao Y, Liu Y, Gong P. Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors. European Journal of Medicinal Chemistry 2016;123:431-46. [DOI: 10.1016/j.ejmech.2016.07.059] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
408 Mizuno S, Nakamura T. Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis. Regen Med 2007;2:161-70. [PMID: 17465748 DOI: 10.2217/17460751.2.2.161] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
409 Schroeder GM, An Y, Cai ZW, Chen XT, Clark C, Cornelius LA, Dai J, Gullo-Brown J, Gupta A, Henley B, Hunt JT, Jeyaseelan R, Kamath A, Kim K, Lippy J, Lombardo LJ, Manne V, Oppenheimer S, Sack JS, Schmidt RJ, Shen G, Stefanski K, Tokarski JS, Trainor GL, Wautlet BS, Wei D, Williams DK, Zhang Y, Zhang Y, Fargnoli J, Borzilleri RM. Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily. J Med Chem 2009;52:1251-4. [PMID: 19260711 DOI: 10.1021/jm801586s] [Cited by in Crossref: 203] [Cited by in F6Publishing: 198] [Article Influence: 16.9] [Reference Citation Analysis]
410 Martins GJ, Plachez C, Powell EM. Loss of Embryonic MET Signaling Alters Profiles of Hippocampal Interneurons. Dev Neurosci 2006;29:143-58. [DOI: 10.1159/000096219] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
411 Mesteri I, Schoppmann SF, Preusser M, Birner P. Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma. Eur J Cancer. 2014;50:1354-1360. [PMID: 24565853 DOI: 10.1016/j.ejca.2014.01.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
412 Furuya K, Zheng YW, Sako D, Iwasaki K, Zheng DX, Ge JY, Liu LP, Furuta T, Akimoto K, Yagi H, Hamada H, Isoda H, Oda T, Ohkohchi N. Enhanced hepatic differentiation in the subpopulation of human amniotic stem cells under 3D multicellular microenvironment. World J Stem Cells 2019; 11(9): 705-721 [PMID: 31616545 DOI: 10.4252/wjsc.v11.i9.705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
413 Song KH, Ellis E, Strom S, Chiang JY. Hepatocyte growth factor signaling pathway inhibits cholesterol 7alpha-hydroxylase and bile acid synthesis in human hepatocytes. Hepatology. 2007;46:1993-2002. [PMID: 17924446 DOI: 10.1002/hep.21878] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
414 Mazzone M, Basilico C, Cavassa S, Pennacchietti S, Risio M, Naldini L, Comoglio PM, Michieli P. An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J Clin Invest 2004;114:1418-32. [PMID: 15545993 DOI: 10.1172/JCI22235] [Cited by in Crossref: 61] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
415 Xie Q, Su Y, Dykema K, Johnson J, Koeman J, De Giorgi V, Huang A, Schlegel R, Essenburg C, Kang L, Iwaya K, Seki S, Khoo SK, Zhang B, Buonaguro F, Marincola FM, Furge K, Vande Woude GF, Shinomiya N. Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy. Genes Cancer 2013;4:247-60. [PMID: 24167653 DOI: 10.1177/1947601913501075] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
416 Shu Z, Deng WM. Differential Regulation of Cyclin E by Yorkie-Scalloped Signaling in Organ Development. G3 (Bethesda) 2017;7:1049-60. [PMID: 28143945 DOI: 10.1534/g3.117.039065] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
417 Böhm F, Speicher T, Hellerbrand C, Dickson C, Partanen JM, Ornitz DM, Werner S. FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice. Gastroenterology. 2010;139:1385-1396. [PMID: 20603121 DOI: 10.1053/j.gastro.2010.06.069] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
418 Gascon E, Gaillard S, Malapert P, Liu Y, Rodat-Despoix L, Samokhvalov IM, Delmas P, Helmbacher F, Maina F, Moqrich A. Hepatocyte growth factor-Met signaling is required for Runx1 extinction and peptidergic differentiation in primary nociceptive neurons. J Neurosci 2010;30:12414-23. [PMID: 20844136 DOI: 10.1523/JNEUROSCI.3135-10.2010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
419 Gonçalves LA, Rodo J, Rodrigues-Duarte L, de Moraes LV, Penha-Gonçalves C. HGF Secreted by Activated Kupffer Cells Induces Apoptosis of Plasmodium-Infected Hepatocytes. Front Immunol 2017;8:90. [PMID: 28220125 DOI: 10.3389/fimmu.2017.00090] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
420 Wirth KM, Kizy S, Steer CJ. Liver Regeneration in the Acute Liver Failure Patient. Clin Liver Dis. 2018;22:269-287. [PMID: 29605066 DOI: 10.1016/j.cld.2018.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
421 Bard-Chapeau EA, Yuan J, Droin N, Long S, Zhang EE, Nguyen TV, Feng GS. Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection. Mol Cell Biol 2006;26:4664-74. [PMID: 16738330 DOI: 10.1128/MCB.02253-05] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
422 Chang W, Song L, Chang X, Ji M, Wang H, Qin X, Niu W. Early activated hepatic stellate cell-derived paracrine molecules modulate acute liver injury and regeneration. Lab Invest. 2017;97:318-328. [PMID: 27991908 DOI: 10.1038/labinvest.2016.130] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
423 Lewis FC, Kumar SD, Ellison-hughes GM. Non-invasive strategies for stimulating endogenous repair and regenerative mechanisms in the damaged heart. Pharmacological Research 2018;127:33-40. [DOI: 10.1016/j.phrs.2017.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
424 Whitworth MK, Sheen A, Rosa DD, Duff SE, Ryder D, Burumdayal A, Wiener K, Hawkins RE, Saunders M, Valle JW, Sherlock D, Jayson GC. Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor. J Cancer Res Clin Oncol 2006;132:41-4. [DOI: 10.1007/s00432-005-0037-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
425 Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310-315. [PMID: 21068842 DOI: 10.1038/nature09493.inductive] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
426 Wang H, Vohra BP, Zhang Y, Heuckeroth RO. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Hepatology. 2005;42:1099-1108. [PMID: 16250054 DOI: 10.1002/hep.20903] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
427 DeAngelis RA, Markiewski MM, Lambris JD. Liver regeneration: a link to inflammation through complement. Adv Exp Med Biol. 2006;586:17-34. [PMID: 16893062 DOI: 10.1007/0-387-34134-X_2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
428 Miller JD, Weiss RM, Heistad DD. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res 2011;108:1392-412. [PMID: 21617136 DOI: 10.1161/CIRCRESAHA.110.234138] [Cited by in Crossref: 178] [Cited by in F6Publishing: 92] [Article Influence: 16.2] [Reference Citation Analysis]
429 Yuan L, Zhang Y, Liu X, Chen Y, Zhang L, Cao J, Li X, Wang M, Wu K, Zhang J, Liu G, Tang Q, Yuan Q, Cheng T, Xia N. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice. Theranostics 2019;9:2115-28. [PMID: 31037160 DOI: 10.7150/thno.30009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
430 Qiu YD, Wang S, Yang Y, Yan XP. Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats. World J Gastroenterol 2012; 18(25): 3288-3295 [PMID: 22783054 DOI: 10.3748/wjg.v18.i25.3288] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
431 Firtina Karagonlar Z, Koc D, Iscan E, Erdal E, Atabey N. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells. Cancer Sci 2016;107:407-16. [PMID: 26790028 DOI: 10.1111/cas.12891] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
432 Fornaro L, Vivaldi C, Caparello C, Sacco R, Rotella V, Musettini G, Luchi S, Baldini EE, Falcone A, Masi G. Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapy. Future Oncol. 2014;10:285-304. [PMID: 24490614 DOI: 10.2217/fon.13.181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
433 Vasavada RC, Gonzalez-Pertusa JA, Fujinaka Y, Fiaschi-Taesch N, Cozar-Castellano I, Garcia-Ocaña A. Growth factors and beta cell replication. Int J Biochem Cell Biol 2006;38:931-50. [PMID: 16168703 DOI: 10.1016/j.biocel.2005.08.003] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 5.6] [Reference Citation Analysis]
434 Gaule PB, Crown J, O'Donovan N, Duffy MJ. cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients? Expert Opin Ther Targets 2014;18:999-1009. [PMID: 25084805 DOI: 10.1517/14728222.2014.938050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
435 Giordano S, Columbano A. Met as a therapeutic target in HCC: facts and hopes. J Hepatol. 2014;60:442-452. [PMID: 24045150 DOI: 10.1016/j.jhep.2013.09.009] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 9.6] [Reference Citation Analysis]
436 Caruso N, Herberth B, Lamballe F, Arce-Gorvel V, Maina F, Helmbacher F. Plasticity versus specificity in RTK signalling modalities for distinct biological outcomes in motor neurons. BMC Biol 2014;12:56. [PMID: 25124859 DOI: 10.1186/s12915-014-0056-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
437 Buck M. Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. PLoS One 2008;3:e2660. [PMID: 18628977 DOI: 10.1371/journal.pone.0002660] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
438 Chan SL, Yeo W. Targeted therapy of hepatocellular carcinoma: Present and future: Novel treatment for liver cancer. Journal of Gastroenterology and Hepatology 2012;27:862-72. [DOI: 10.1111/j.1440-1746.2012.07096.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
439 Duplaquet L, Leroy C, Vinchent A, Paget S, Lefebvre J, Vanden Abeele F, Lancel S, Giffard F, Paumelle R, Bidaux G, Heliot L, Poulain L, Furlan A, Tulasne D. Control of cell death/survival balance by the MET dependence receptor. Elife 2020;9:e50041. [PMID: 32091387 DOI: 10.7554/eLife.50041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
440 Dasgupta A, Hughey R, Lancin P, Larue L, Moghe PV. E-cadherin synergistically induces hepatospecific phenotype and maturation of embryonic stem cells in conjunction with hepatotrophic factors. Biotechnol Bioeng 2005;92:257-66. [PMID: 16167333 DOI: 10.1002/bit.20676] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
441 Wang L, Li S, Wang HY, Zeng J, Zhang ZZ, Lv DY, Kuang WH. In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met Pathway. Evid Based Complement Alternat Med 2019;2019:4253846. [PMID: 31915446 DOI: 10.1155/2019/4253846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
442 Minamino T, Ito Y, Ohkubo H, Shimuzu Y, Kojo K, Nishizwa N, Amano H, Narumiya S, Koizumi W, Majima M. Adhesion of platelets through thromboxane A₂ receptor signaling facilitates liver repair during acute chemical-induced hepatotoxicity. Life Sci 2015;132:85-92. [PMID: 25921763 DOI: 10.1016/j.lfs.2015.03.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
443 Khan MGM, Ghosh A, Variya B, Santharam MA, Kandhi R, Ramanathan S, Ilangumaran S. Hepatocyte growth control by SOCS1 and SOCS3. Cytokine. 2019;121:154733. [PMID: 31154249 DOI: 10.1016/j.cyto.2019.154733] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
444 Sun R, Jaruga B, Kulkarni S, Sun H, Gao B. IL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1: regulation by SOCS3. Biochem Biophys Res Commun 2005;338:1943-9. [PMID: 16288983 DOI: 10.1016/j.bbrc.2005.10.171] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
445 Duarte S, Hamada T, Kuriyama N, Busuttil RW, Coito AJ. TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury. Hepatology 2012;56:1074-85. [PMID: 22407827 DOI: 10.1002/hep.25710] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
446 Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer 2010;46:1260-70. [PMID: 20303741 DOI: 10.1016/j.ejca.2010.02.028] [Cited by in Crossref: 139] [Cited by in F6Publishing: 137] [Article Influence: 11.6] [Reference Citation Analysis]
447 Oh YM, Song YJ, Lee SB, Jeong Y, Kim B, Kim GW, Kim KE, Lee JM, Cho MY, Choi J, Nam DH, Song PH, Cheong KH, Kim KA. A new anti-c-Met antibody selected by a mechanism-based dual-screening method: therapeutic potential in cancer. Mol Cells 2012;34:523-9. [PMID: 23180291 DOI: 10.1007/s10059-012-0194-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
448 De Silva DM, Roy A, Kato T, Cecchi F, Lee YH, Matsumoto K, Bottaro DP. Targeting the hepatocyte growth factor/Met pathway in cancer. Biochem Soc Trans 2017;45:855-70. [PMID: 28673936 DOI: 10.1042/BST20160132] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
449 Gomez-Quiroz LE, Seo D, Lee YH, Kitade M, Gaiser T, Gillen M, Lee SB, Gutierrez-Ruiz MC, Conner EA, Factor VM, Thorgeirsson SS, Marquardt JU. Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress. Toxicology 2016;361-362:39-48. [PMID: 27394961 DOI: 10.1016/j.tox.2016.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
450 Rudnick DA. Trimming the fat from liver regeneration. Hepatology 2005;42:1001-3. [DOI: 10.1002/hep.20931] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
451 Christophi C, Harun N, Fifis T. Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors. J Gastrointest Surg. 2008;12:966-980. [PMID: 18181006 DOI: 10.1007/s11605-0070459-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
452 Venepalli NK, Goff L. Targeting the HGF-cMET Axis in Hepatocellular Carcinoma. Int J Hepatol. 2013;2013:341636. [PMID: 23606971 DOI: 10.1155/2013/341636] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
453 Fakhoury M. Imaging genetics in autism spectrum disorders: Linking genetics and brain imaging in the pursuit of the underlying neurobiological mechanisms. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;80:101-14. [DOI: 10.1016/j.pnpbp.2017.02.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
454 Kitade M, Factor VM, Andersen JB, Tomokuni A, Kaji K, Akita H, Holczbauer A, Seo D, Marquardt JU, Conner EA, Lee SB, Lee YH, Thorgeirsson SS. Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling. Genes Dev 2013;27:1706-17. [PMID: 23913923 DOI: 10.1101/gad.214601.113] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
455 Klotz DM, Link T, Goeckenjan M, Wimberger P, Kuhlmann JD. The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker. Mol Oncol 2021;15:2491-503. [PMID: 33690968 DOI: 10.1002/1878-0261.12939] [Reference Citation Analysis]
456 Ohnishi H, Oka K, Mizuno S, Nakamura T. Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis. J Biol Chem 2012;287:13371-81. [PMID: 22354962 DOI: 10.1074/jbc.M111.318568] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
457 Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K. Transglutaminase regulation of cell function. Physiol Rev 2014;94:383-417. [PMID: 24692352 DOI: 10.1152/physrev.00019.2013] [Cited by in Crossref: 217] [Cited by in F6Publishing: 206] [Article Influence: 27.1] [Reference Citation Analysis]
458 Sangwan V, Paliouras GN, Abella JV, Dubé N, Monast A, Tremblay ML, Park M. Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase. J Biol Chem 2008;283:34374-83. [PMID: 18819921 DOI: 10.1074/jbc.M805916200] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
459 Segura-Carretero A, Curiel JA. Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent. Int J Mol Sci 2018;19:E2899. [PMID: 30250008 DOI: 10.3390/ijms19102899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
460 Yang LL, Luo Y. Liver regeneration after partial hepatectomy. Shijie Huaren Xiaohua Zazhi 2016; 24(1): 67-74 [DOI: 10.11569/wcjd.v24.i1.67] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
461 Nejak-Bowen K, Orr A, Bowen WC Jr, Michalopoulos GK. Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy. PLoS One 2013;8:e59836. [PMID: 23527275 DOI: 10.1371/journal.pone.0059836] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
462 Dittmar Y, Settmacher U. Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological features. World J Gastrointest Oncol 2015; 7(11): 292-302 [PMID: 26600929 DOI: 10.4251/wjgo.v7.i11.292] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
463 Kojima S, Kuo TF, Tatsukawa H, Hirose S. Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways. Dig Dis 2010;28:715-21. [PMID: 21525755 DOI: 10.1159/000324278] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
464 Tang Y, Li Q, Meng F, Huang X, Li C, Zhou X, Zeng X, He Y, Liu J, Hu X, Hu JF, Li T. Therapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver Failure. Int J Hepatol 2016;2016:5452487. [PMID: 27057357 DOI: 10.1155/2016/5452487] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
465 Cañadas I, Rojo F, Arumí-Uría M, Rovira A, Albanell J, Arriola E. C-MET as a new therapeutic target for the development of novel anticancer drugs. Clin Transl Oncol 2010;12:253-60. [PMID: 20462834 DOI: 10.1007/s12094-010-0501-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
466 Revel-Mouroz P, Otal P, Jaffro M, Petermann A, Meyrignac O, Rabinel P, Mokrane FZ. Other non-surgical treatments for liver cancer. Rep Pract Oncol Radiother 2017;22:181-92. [PMID: 28490991 DOI: 10.1016/j.rpor.2017.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
467 Webster MT, Fan CM. c-MET regulates myoblast motility and myocyte fusion during adult skeletal muscle regeneration. PLoS One 2013;8:e81757. [PMID: 24260586 DOI: 10.1371/journal.pone.0081757] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
468 Gaziova I, Jackson D, Boor PJ, Carter D, Cruz-Monserrate Z, Elferink CJ, Joshi AD, Kaphalia B, Logsdon CD, Pereira de Castro K, Soong L, Tao X, Qiu S, Elferink LA. The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury. PLoS One 2016;11:e0165485. [PMID: 27798657 DOI: 10.1371/journal.pone.0165485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
469 Yu J, Zhang W, Qian H, Tang H, Lin W, Lu B. SOCS1 regulates hepatic regenerative response and provides prognostic makers for acute obstructive cholangitis. Sci Rep 2017;7:9482. [PMID: 28842621 DOI: 10.1038/s41598-017-09865-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
470 Motoki T, Sugiura Y, Matsumoto Y, Tsuji T, Kubota S, Takigawa M, Gohda E. Induction of hepatocyte growth factor expression by maleic acid in human fibroblasts through MAPK activation. J Cell Biochem 2008;104:1465-76. [DOI: 10.1002/jcb.21724] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
471 Nagamoto Y, Takayama K, Ohashi K, Okamoto R, Sakurai F, Tachibana M, Kawabata K, Mizuguchi H. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. J Hepatol. 2016;64:1068-1075. [PMID: 26778754 DOI: 10.1016/j.jhep.2016.01.004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 12.3] [Reference Citation Analysis]
472 Li K, Qi X, Yang J, Gong J, Tan C, Xia Q, Long J, Wang Z. Losartan supports liver regrowth via distinct boost of portal vein pressure in rodents with 90 % portal branch ligation. Dig Dis Sci 2013;58:2205-11. [PMID: 23633154 DOI: 10.1007/s10620-013-2664-3] [Reference Citation Analysis]
473 Basilico C, Arnesano A, Galluzzo M, Comoglio PM, Michieli P. A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met. J Biol Chem 2008;283:21267-77. [PMID: 18495663 DOI: 10.1074/jbc.M800727200] [Cited by in Crossref: 84] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
474 Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:588-610. [PMID: 20551596 DOI: 10.2183/pjab.86.588] [Cited by in Crossref: 261] [Cited by in F6Publishing: 246] [Article Influence: 23.7] [Reference Citation Analysis]
475 Pérez-Ramírez C, Cañadas-Garre M, Jiménez-Varo E, Faus-Dáder MJ, Calleja-Hernández MÁ. MET: a new promising biomarker in non-small-cell lung carcinoma. Pharmacogenomics 2015;16:631-47. [PMID: 25893986 DOI: 10.2217/pgs.15.11] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
476 Burdick KE, DeRosse P, Kane JM, Lencz T, Malhotra AK. Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability. Am J Psychiatry 2010;167:436-43. [PMID: 20080979 DOI: 10.1176/appi.ajp.2009.09050615] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
477 Peruzzi B, Athauda G, Bottaro DP. The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proc Natl Acad Sci U S A 2006;103:14531-6. [PMID: 16983094 DOI: 10.1073/pnas.0606850103] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 4.7] [Reference Citation Analysis]
478 Baier P, Wolf-Vorbeck G, Hempel S, Hopt U, Dobschuetz EV. Effect of liver regeneration after partial hepatectomy and ischemia-reperfusion on expression of growth factor receptors. World J Gastroenterol 2006; 12(24): 3835-3840 [PMID: 16804967 DOI: 10.3748/wjg.v12.i24.3835] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
479 Zhao Y, Difrancesca D, Wang X, Zarnegar R, Michalopoulos GK, Yin XM. Promotion of Fas-mediated apoptosis in Type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement. J Cell Physiol 2007;213:556-63. [PMID: 17620325 DOI: 10.1002/jcp.21136] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
480 Lamballe F, Genestine M, Caruso N, Arce V, Richelme S, Helmbacher F, Maina F. Pool-specific regulation of motor neuron survival by neurotrophic support. J Neurosci 2011;31:11144-58. [PMID: 21813676 DOI: 10.1523/JNEUROSCI.2198-11.2011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
481 Arterbery AS, Bogue CW. Endodermal and mesenchymal cross talk: a crossroad for the maturation of foregut organs. Pediatr Res 2014;75:120-6. [DOI: 10.1038/pr.2013.201] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
482 Saito Y, Kuwahara Y, Yamamoto Y, Suzuki M, Fukumoto M, Yamamoto F. ddY Mice Fed 10% Fat Diet Exhibit High p27KIP Expression and Delayed Hepatocyte DNA Synthesis During Liver Regeneration. Metabolic Syndrome and Related Disorders 2018;16:305-13. [DOI: 10.1089/met.2017.0131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
483 Matsumoto K, Funakoshi H, Takahashi H, Sakai K. HGF-Met Pathway in Regeneration and Drug Discovery. Biomedicines 2014;2:275-300. [PMID: 28548072 DOI: 10.3390/biomedicines2040275] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
484 Kurinna S, Barton MC. Cascades of transcription regulation during liver regeneration. Int J Biochem Cell Biol. 2011;43:189-197. [PMID: 20307684 DOI: 10.1016/j.biocel.2010.03.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
485 Coudriet GM, He J, Trucco M, Mars WM, Piganelli JD. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One 2010;5:e15384. [PMID: 21072211 DOI: 10.1371/journal.pone.0015384] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
486 Brandes F, Schmidt K, Wagner C, Redekopf J, Schlitt HJ, Geissler EK, Lang SA. Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model. BMC Cancer. 2015;15:71. [PMID: 25884642 DOI: 10.1186/s12885-015-1064-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
487 Gherardi E, Birchmeier W, Birchmeier C, Woude GV. Targeting MET in cancer: rationale and progress. Nat Rev Cancer 2012;12:89-103. [DOI: 10.1038/nrc3205] [Cited by in Crossref: 948] [Cited by in F6Publishing: 900] [Article Influence: 94.8] [Reference Citation Analysis]
488 Heuer L, Braunschweig D, Ashwood P, Van de Water J, Campbell DB. Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Transl Psychiatry 2011;1:e48. [PMID: 22833194 DOI: 10.1038/tp.2011.48] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
489 Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-47. [DOI: 10.1038/nrm1489] [Cited by in Crossref: 1020] [Cited by in F6Publishing: 970] [Article Influence: 56.7] [Reference Citation Analysis]
490 Michalopoulos GK. Liver Regeneration. In: Monga SPS, editor. Molecular Pathology of Liver Diseases. Boston: Springer US; 2011. pp. 261-78. [DOI: 10.1007/978-1-4419-7107-4_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
491 Tang Q, Zhang G, Du X, Zhu W, Li R, Lin H, Li P, Cheng M, Gong P, Zhao Y. Discovery of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 5-(aminomethylene)pyrimidine-2,4,6-trione moiety as c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry 2014;22:1236-49. [DOI: 10.1016/j.bmc.2014.01.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
492 Choi JW, Kim YS, Park JK, Song EH, Park JH, Kim MS, Shin YS, Kim CH. Controlled Release of Hepatocyte Growth Factor from MPEG-b-(PCL-ran-PLLA) Diblock Copolymer for Improved Vocal Fold Regeneration. Macromol Biosci 2017;17. [PMID: 27648819 DOI: 10.1002/mabi.201600163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
493 Furlan A, Lamballe F, Stagni V, Hussain A, Richelme S, Prodosmo A, Moumen A, Brun C, Del Barco Barrantes I, Arthur JS, Koleske AJ, Nebreda AR, Barilà D, Maina F. Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver. J Hepatol 2012;57:1292-8. [PMID: 22889954 DOI: 10.1016/j.jhep.2012.07.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
494 Tormos AM, Taléns-Visconti R, Nebreda AR, Sastre J. p38 MAPK: a dual role in hepatocyte proliferation through reactive oxygen species. Free Radic Res 2013;47:905-16. [PMID: 23906070 DOI: 10.3109/10715762.2013.821200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
495 Yin J, Hu W, Xue X, Fu W, Dai L, Jiang Z, Zhong S, Deng B, Zhao J. Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer. J Cancer 2019;10:5070-81. [PMID: 31602259 DOI: 10.7150/jca.30034] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
496 Elchaninov A, Fatkhudinov T, Makarov A, Vorobieva I, Lokhonina A, Usman N, Kananykhina E, Vishnyakova P, Nikitina M, Goldshtein D, Bolshakova G, Glinkina V, Sukhikh G. Inherent control of hepatocyte proliferation after subtotal liver resection. Cell Biol Int. 2019;. [PMID: 31297922 DOI: 10.1002/cbin.11203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
497 Li Z, Chen J, Li L, Ran JH, Li XH, Liu ZH, Liu GJ, Gao YC, Zhang XL, Sun HD. In vitro and in vivo characteristics of hepatic oval cells modified with human hepatocyte growth factor. Cell Mol Biol Lett. 2013;18:507-521. [PMID: 24005538 DOI: 10.2478/s11658-013-0104-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
498 Yang H, Zhou Z, Lin L, Yang M, Li C, Li Z, Yu X, Lizaso A, Han-Zhang H, Li B, Xiang J, Mao X, Xu Q, Zhang Y, Yang N. Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers. Lung Cancer 2020;148:113-21. [PMID: 32889305 DOI: 10.1016/j.lungcan.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
499 Liu Z, Liu X, Liang J, Liu Y, Hou X, Zhang M, Li Y, Jiang X. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects. Front Immunol 2021;12:765101. [PMID: 34675942 DOI: 10.3389/fimmu.2021.765101] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
500 Yang W, Zhao X, Tao Y, Wu Y, He F, Tang L. Proteomic analysis reveals a protective role of specific macrophage subsets in liver repair. Sci Rep 2019;9:2953. [PMID: 30814596 DOI: 10.1038/s41598-019-39007-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
501 Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets 2012;16:553-72. [PMID: 22530990 DOI: 10.1517/14728222.2012.680957] [Cited by in Crossref: 149] [Cited by in F6Publishing: 139] [Article Influence: 14.9] [Reference Citation Analysis]
502 Zhai X, Bao G, Wang L, Cheng M, Zhao M, Zhao S, Zhou H, Gong P. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry 2016;24:1331-45. [DOI: 10.1016/j.bmc.2016.02.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
503 Rodgers JT, King KY, Brett JO, Cromie MJ, Charville GW, Maguire KK, Brunson C, Mastey N, Liu L, Tsai CR, Goodell MA, Rando TA. mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). Nature 2014;510:393-6. [PMID: 24870234 DOI: 10.1038/nature13255] [Cited by in Crossref: 368] [Cited by in F6Publishing: 332] [Article Influence: 46.0] [Reference Citation Analysis]
504 Gherardi E, Sandin S, Petoukhov MV, Finch J, Youles ME, Ofverstedt LG, Miguel RN, Blundell TL, Vande Woude GF, Skoglund U, Svergun DI. Structural basis of hepatocyte growth factor/scatter factor and MET signalling. Proc Natl Acad Sci U S A 2006;103:4046-51. [PMID: 16537482 DOI: 10.1073/pnas.0509040103] [Cited by in Crossref: 152] [Cited by in F6Publishing: 139] [Article Influence: 9.5] [Reference Citation Analysis]
505 Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006;12:410-416. [PMID: 16532004 DOI: 10.1038/nm1377] [Cited by in Crossref: 677] [Cited by in F6Publishing: 641] [Article Influence: 42.3] [Reference Citation Analysis]
506 Eichbaum MH, de Rossi TM, Kaul S, Bruckner T, Schneeweiss A, Sohn C. Serum levels of hepatocyte growth factor/scatter factor in patients with liver metastases from breast cancer. Tumour Biol 2007;28:36-44. [PMID: 17143015 DOI: 10.1159/000097701] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
507 Riordan JD, Feddersen CR, Tschida BR, Beckmann PJ, Keng VW, Linden MA, Amin K, Stipp CS, Largaespada DA, Dupuy AJ. Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice. Hepatology. 2018;67:924-939. [PMID: 28961327 DOI: 10.1002/hep.29565] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
508 Dai JY, DeFrances MC, Zou C, Johnson CJ, Zarnegar R. The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival. J Cell Biochem 2009;107:1222-36. [PMID: 19530226 DOI: 10.1002/jcb.22226] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
509 Gastaldi S, Comoglio PM, Trusolino L. The Met oncogene and basal-like breast cancer: another culprit to watch out for? Breast Cancer Res 2010;12:208. [PMID: 20804567 DOI: 10.1186/bcr2617] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
510 Ugolini A, Kenigsberg M, Rak A, Vallée F, Houtmann J, Lowinski M, Capdevila C, Khider J, Albert E, Martinet N, Nemecek C, Grapinet S, Bacqué E, Roesner M, Delaisi C, Calvet L, Bonche F, Semiond D, Egile C, Goulaouic H, Schio L. Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3- b ]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844). J Med Chem 2016;59:7066-74. [DOI: 10.1021/acs.jmedchem.6b00280] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
511 Calvi C, Podowski M, Lopez-Mercado A, Metzger S, Misono K, Malinina A, Dikeman D, Poonyagariyon H, Ynalvez L, Derakhshandeh R, Le A, Merchant M, Schwall R, Neptune ER. Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung. PLoS Genet 2013;9:e1003228. [PMID: 23459311 DOI: 10.1371/journal.pgen.1003228] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
512 Hardy-Werbin M, Del Rey-Vergara R, Galindo-Campos MA, Moliner L, Arriola E. MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside. Cancers (Basel) 2019;11:E1404. [PMID: 31547040 DOI: 10.3390/cancers11101404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
513 Lv H, Shan B, Tian Z, Li Y, Zhang Y, Wen S. Soluble c-Met is a reliable and sensitive marker to detect c-Met expression level in lung cancer. Biomed Res Int 2015;2015:626578. [PMID: 25834821 DOI: 10.1155/2015/626578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
514 Kamitakahara AK, Ali Marandi Ghoddousi R, Lanjewar AL, Magalong VM, Wu HH, Levitt P. MET Receptor Tyrosine Kinase Regulates Lifespan Ultrasonic Vocalization and Vagal Motor Neuron Development. Front Neurosci 2021;15:768577. [PMID: 34803597 DOI: 10.3389/fnins.2021.768577] [Reference Citation Analysis]
515 Varela-Rey M, Beraza N, Lu SC, Mato JM, Martínez-Chantar ML. Role of AMP-activated protein kinase in the control of hepatocyte priming and proliferation during liver regeneration. Exp Biol Med (Maywood) 2011;236:402-8. [PMID: 21427236 DOI: 10.1258/ebm.2011.010352] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
516 Tatsukawa H, Furutani Y, Hitomi K, Kojima S. Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis 2016;7:e2244. [PMID: 27253408 DOI: 10.1038/cddis.2016.150] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 12.5] [Reference Citation Analysis]
517 Fukuda T, Fukuchi T, Yagi S, Shiojiri N. Immunohistochemical analyses of cell cycle progression and gene expression of biliary epithelial cells during liver regeneration after partial hepatectomy of the mouse. Exp Anim 2016;65:135-46. [PMID: 26633692 DOI: 10.1538/expanim.15-0082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
518 Perez RA, Jung CR, Kim HW. Biomaterials and Culture Technologies for Regenerative Therapy of Liver Tissue. Adv Healthc Mater 2017;6. [PMID: 27860372 DOI: 10.1002/adhm.201600791] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
519 Gao X, Lorinczi M, Hill KS, Brooks NC, Dokainish H, Ireton K, Elferink LA. Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B. J Biol Chem 2009;284:774-83. [PMID: 18990695 DOI: 10.1074/jbc.M805989200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
520 Gao C, Yang Y, Zhang Y, Qian M, Yang J. HGF Gene Delivering Alginate/Galactosylated Chitosan Sponge Scaffold for Three-Dimensional Coculture of Hepatocytes/3T3 Cells. DNA Cell Biol 2020;39:451-8. [PMID: 31910350 DOI: 10.1089/dna.2019.5136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
521 Montagne R, Baranzelli A, Muharram G, Catherine L, Lesaffre M, Vinchent A, Kherrouche Z, Werkmeister E, Cortot AB, Tulasne D. MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering. Oncotarget 2017;8:11268-83. [PMID: 28061464 DOI: 10.18632/oncotarget.14499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
522 Mitchell C, Nivison M, Jackson LF, Fox R, Lee DC, Campbell JS, Fausto N. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem. 2005;280:2562-2568. [PMID: 15536070 DOI: 10.1074/jbc.m412372200] [Cited by in Crossref: 108] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
523 Towner RA, Smith N, Asano Y, Doblas S, Saunders D, Silasi-Mansat R, Lupu F. Molecular magnetic resonance imaging approaches used to aid in the understanding of the tissue regeneration marker Met in vivo: implications for tissue engineering. Tissue Eng Part A 2010;16:365-71. [PMID: 19905873 DOI: 10.1089/ten.TEA.2009.0234] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]